WO2008059906A1 - External preparation for skin and external preparation for mucosa - Google Patents

External preparation for skin and external preparation for mucosa Download PDF

Info

Publication number
WO2008059906A1
WO2008059906A1 PCT/JP2007/072150 JP2007072150W WO2008059906A1 WO 2008059906 A1 WO2008059906 A1 WO 2008059906A1 JP 2007072150 W JP2007072150 W JP 2007072150W WO 2008059906 A1 WO2008059906 A1 WO 2008059906A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
external preparation
extract
effect
mucosa
Prior art date
Application number
PCT/JP2007/072150
Other languages
French (fr)
Japanese (ja)
Inventor
Yoshiharu Kawagoe
Masafumi Akatsuka
Yumi Ohara
Original Assignee
Nozaki, Katsunori
Kamata, Yasushi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2007285634A external-priority patent/JP2008273922A/en
Application filed by Nozaki, Katsunori, Kamata, Yasushi filed Critical Nozaki, Katsunori
Publication of WO2008059906A1 publication Critical patent/WO2008059906A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9761Cupressaceae [Cypress family], e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention allows the skin to penetrate the inside of the skin percutaneously by applying, immersing, rubbing or contacting the skin, thereby reducing or fading the stains and soaks that have already been formed.
  • external preparations for skin used to restore the original color of the skin external preparations for external use for skin can be used mainly as basic cosmetics such as lotions, cosmetic creams, bath preparations, soaps for medicinal use, etc.
  • the present invention relates to an external preparation for mucous membrane which exerts an excellent antiallergic action and an antihistamine action by acting on mucous membranes. Background art
  • vitamin C tocopherol
  • SOD dodismutase
  • vitamins C and E are generally unstable, and have an adverse effect on oxidized vitamin A and oxidized vitamin E that are produced after oxidation with active oxygen. It is not satisfactory in terms of points. Synthetic antioxidants with excellent stability tend to be reluctant from recent consumer safety, natural and health concerns.
  • Patent Document 1 discloses, as a melanin production inhibitor based on the inhibition of tyrosinase activity, a skin cosmetic containing a herbal extract such as curcuma versifolium and cucumber.
  • the cucon extract used herein is an extract obtained by extracting the rhizome of cucon with a hydrophilic organic solvent such as water, methanol, or ethanol.
  • crude drug extracts such as banshu, cowpea, and persimmon are excellent in the antioxidant action against unsaturated fatty acid and active oxygen scavenging action, and the external preparation for skin containing these is superior to vitamin E for the improvement of blur.
  • the extract of Bankon used in this case is a hot water extract of the rhizome, an ethanol extract of whole grass, an extract of 1, 3-butylene glycol of the rhizome, and the excellent antioxidant of the extract By action, it is intended to improve skin, skin, skin and dullness.
  • Patent Document 3 discloses water-soluble thickeners such as glycerol and hyaluronic acid Na, antibacterial alcohols such as ethanol, antioxidant vitamins such as tocopherols, and anti-inflammatory agents such as mefenamic acid and tranexamic acid.
  • a cosmetic composition to which a botan extract, a button, an aloe, a carrot, a plant extract such as curcuma has been added as a whitening component.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 6-2 2 7 9 6 0
  • Patent Document 2 Japanese Patent Application Laid-Open No. 200002 1 2 1 1 4 4
  • Patent Document 3 Japanese Patent Application Laid-Open Publication No. 200002-2 0 1 2 0 5 2
  • the scavenging of reactive oxygen species by the antioxidant component is intended to suppress the formation of stains and griefs by ultraviolet irradiation, and against the whitening effects such as reduction, disappearance, and fading of stains and romances that have already been formed, Further improvement is desired.
  • it also has a moisturizing effect to keep the skin moist, inflammation, anti-allergy, and skin lightening effects as long as it is effective in preventing and suppressing skin aging. There is a strong demand for development of such external skin preparations.
  • the present invention has been made in view of these circumstances, and it has a skin-whitening effect to rejuvenate the skin's original color and wrinkles by reducing sunburn due to ultraviolet irradiation, reducing stains due to aging and fading off. At the same time, it is effective in removing active oxygen, moisturizing, inflammation, anti-allergy, prevention of skin aging, etc., and it is possible to obtain a more beautiful skin effect.
  • An external preparation for skin which can be expected to treat or alleviate eryrgic dermatitis and the like, and an external preparation for mucous membrane which exerts an excellent antiallergic action and an antihistaminic action by acting on mucous membranes To aim. Means to solve the problem
  • the external preparation for skin of the present invention is characterized in that it contains an extract of leaves and Z or a stem of a plant belonging to the genus Rosaceae of the family Rosaceae as an active ingredient.
  • the external preparation for mucous membrane of the present invention is characterized by containing extracts of leaves and stems of a plant belonging to the genus Rosaceae of the family Rosaceae as active ingredients. Effect of the invention
  • the external preparation for skin of the present invention is percutaneously incorporated into the skin to inhibit the activity of tyrosinase, thereby suppressing the formation of melanin which is a cause of the stain, and further along with the turnover of the skin. Since it can be expected to reduce stains and stains that have already been made, it is effective as a whitening essence to be added to cosmetics and bath agents. In addition to the tyrosinase inhibitory activity effect, the external preparation for skin of the present invention also exhibits an active oxygen scavenging effect because it exhibits an excellent SOD-like activity value.
  • the external preparation for skin of the present invention exhibits excellent hyaluronidase inhibition value together with tyrosinase inhibitory activity effect and active oxygen scavenging effect, and thus a moisturizing effect for keeping the skin moist, inflammation, anti-allergy One symptom ⁇
  • a moisturizing effect for keeping the skin moist, inflammation, anti-allergy One symptom ⁇ A more beautiful skin effect can be obtained if it is effective in preventing and suppressing skin aging.
  • due to its excellent anti-allergic action it can also be expected to have a therapeutic or alleviating effect on allergies such as dermatitis.
  • the external preparation for mucous membrane of the present invention acts on the mucous membrane to exert an excellent anti-allergic action and anti-histamine action, and in particular, acts on the nasal mucous membrane to alleviate the symptoms of so-called pollinosis such as runny nose and sores. Can. Brief description of the drawings
  • Fig. 1 Fraction of strawberry leaf extract and measurement results of tyrosinase inhibitory activity.
  • Figure 3 shows the structural formula of q u e r c t i n — 3 — o — D — g l.
  • Figure 5 shows the estimated structure of C o m p o u n d 1
  • FIG. 8 Spectrum of 13 C- NMR of Casuarictin.
  • Figure 9 shows the structural formula of C asuarictin.
  • the external preparation for skin of the present invention contains the extract of leaves and Z or stems of a Rosaceae L. plant as a active ingredient.
  • Rosaceae family Dutch strawberry plant used in the present invention if it is a so-called edible Dutch strawberry, it is possible to use a variety of mulberry species.
  • mulberry species For example, Toyo Noka, Nyoho, Tochiotome, Chapter princess (Akihime), Iberly, Tochihime, Red pearl, Sachi's power Ama, Treasure early birth, Benihopope, etc. Plants can be used.
  • the plant to be used needs to be a plant belonging to the genus Rosaceae, but not intended to be limited to the above-mentioned varieties.
  • an extraction solvent used to extract an extract of the genus Rosaceae L. planta the purpose of use of the product to be provided, type or processing to be performed later although it may be selected in consideration of the etc., it is preferable to use the extract of leaves and Z or stem of the above-mentioned Rosaceae Lubifer plant as extract extracted with water and / or alcohol. By doing this, it is considered that it is possible to extract effectively without destroying the effective ingredients for the beautifying skin.
  • lower alcohols such as methanol, ethanol, propyl alcohol, isopro pinole alcohol, butanol, etc .
  • polyhydric alcohols such as propylidene alcohol, 1, 3-butyleneglycolone, glycerin etc. are used. be able to. These can be used alone or in combination.
  • the extraction may be performed in multiple steps, for example, extraction with leaves of leaves and stems of the genus Rosaceae and the stem with water and then extraction with medanol, but in order to increase the content of the whitening component It is preferable to include an extraction step with a mixture of water and ethanol.
  • the extract-containing solution extracted with these solvents may be used as it is as a skin external preparation, or may be used after being subjected to processing such as concentration, dilution, filtration, drying and the like as necessary.
  • the alcohol may be volatilized by drying or the like to obtain a powder having a high content of the whitening component.
  • the leaves and stems of the above-mentioned Rosaceae Lubiferus plants can be used as long as the plants are grown as edible fruits. It is preferred to use. This is because leaves and / or stems after fruit harvest which have been conventionally discarded are effectively used from the viewpoint of recycling.
  • the leaves and Z or stalks of the above-mentioned Rosaceae L. plant are collected and can be extracted with water and Z or alcohol as they are. Forced after extraction, natural drying or artificial After being dried Extraction with water and / or alcohol is preferred. By doing this, it is considered that the extract concentrated by drying can be extracted. In addition, drying stabilizes the condition of leaves and green leaves or stems, reduces variations in conditions, stabilizes the quality of the extract to be extracted, and improves the shelf life of leaves and Z or stems. This is because the handling is significantly improved.
  • the extraction method may be extraction with water only or alcohol only, or extraction with a mixture of water and alcohol. It can also be extracted by heating, but extraction at normal temperature is preferred. It is because it is thought that the breakage of the extract due to heating is reduced and the effective ingredient for the beautifying skin is effectively extracted.
  • the external preparation for skin of the present invention may be used by adding the extract of leaves and Z of stem or sock of the Rosaceae family to an appropriate solvent and base, or the extract as an essence, and cosmetics. Or add it to quasi-drugs. More specifically, skin cleansing agents such as cleansing creams, cleansing lotions, facial cleansing creams, soaps, etc. as well as whitening agents; moisturizing lotions, soft lotions, skin conditioning agents such as astringent lotions; Milky lotions Protection agents such as emollient milk and vanishing cream; activators such as massage cream, massage system, foam pack, peel off pack etc .; bath additives; and whitening agents may be added as whitening ingredients. In any case, the active ingredient is incorporated into the skin and can be used to cause stains and buckwheat discoloration, reduction and disappearance.
  • the content ratio of leaf and Z or stem extract of Rosaceae L. plant in the final product is appropriately selected according to the type of final product, but in the case of cosmetics, about 1 to 80 mass% is preferable .
  • the external preparation for skin of the present invention does not impair the effect of the extract depending on the final product.
  • base moisturizer, thickener, surfactant, pH adjustment agent, preservative, fragrance, moisturizer, UV absorber, thickener, pigment, antioxidant, chelate component can do.
  • solid oily raw materials such as beeswax, cacao oil; carnaval roux, higher fatty acids, solid paraffin, cetyl alcohol, stearyl alcohol etc .; semi-solid oily raw materials such as wa- seline, lanolin etc; Leave oil, castor oil, palm oil, peanut oil, liquid paraffin, oleic acid, linoleic acid, octoyldodecyl dodecyl myristate, silicone oil, etc. can be used.
  • moisturizing agents such as glycerin, sorbitol, polyethylene glycol, pyrrolidone carboxylic acid and salts thereof, collagen, hyaluronic acid and salts thereof, chondroitin sulfate and salts thereof, and the like; And polyvinyl cinolea / leconole, xanthan gum, ruboxy vinyl polymer, hydroxy propyl cellulose, thickeners such as arabic gum, and the like are used.
  • non-ionic surfactants such as polyethylene glycol isostearylate, sorbitan stearate, glyceryl fatty acid ester, polyoxyethylene hexyl decyl ether, etc .; sodium lauryl sulfate, lauryl phosphate
  • Anionic surfactants such as sodium phosphate
  • cationic surfactants such as stearyldimethylbenzyl ammonium
  • natural surfactants such as sucrose fatty acid ester, sodium caseinate, lecithin, collagen etc.
  • pH adjusters examples include carbonated lithium, sodium bicarbonate, ammonium bicarbonate and the like.
  • paradimethylamino benzoic acid, urocanic acid ethyl, diisopropyl cinnamic acid ethyl, and 2-hydric acid may be added as required.
  • UV absorbers such as droxy 4-methoxybenzophenone and salicylate triethanolamine; preservatives such as cetylparaben and butylparaben; glycyrrhizinic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, Hinokitiol, zinc oxide, allan Anti-inflammatory agents such as toin etc.
  • Vitamins A such as retinol palmitate, vitamins B such as riboflavin, nicotinic acid amide, vitamins D such as colecalciferol, d 1 ⁇ ⁇ -tocopherol etc.
  • Antioxidants such as vitamins and cetaceans; antioxidants such as sodium sorbirate sodium, sage extract, parahydroxyl sole, etc .; active agents such as royal jelly, collesterol derivative various amino acids; ⁇ — orizanol , Blood circulation enhancers such as sodium dextran sulfate; It includes other plant extracts; low force Sami down, colorant safflower like.
  • Extract sample 1 (leaf) and extract sample 2 (stem) were examined for their inhibitory effect on tyroxinase activity, an enzyme involved in the formation of melanin.
  • Tyrosinase (EC1.14.18.1) is a bioenzyme that oxidizes L-tyroosine to L-DOPA and oxidizes L-DOPA to DOPA-quinone. Since DOPA quinone is a causative agent of melanine which is a causative agent of stains and freckles, it is considered that inhibiting tyrosinase can prevent the formation of stains and freckles.
  • the sample (20 ⁇ L) dissolved in phosphate buffer (pH 6. 8) containing 20% DM SO was suspended on a substrate (100; z L) containing 0.1 ML-DO.
  • the turbid enzyme solution (mushroom-derived tyrosinase 30 U, manufactured by SIGMA, 20 ⁇ L ⁇ ) was thoroughly mixed and subjected to enzyme reaction for 15 minutes in a thermostat bath at 37 ° C. After that, 0.1 N aqueous solution of HCl (20 ⁇ L) was added as a reaction stop solution (S).
  • S reaction stop solution
  • the phosphate buffer pH 6.8 was used as a measurement blank, and the absorbance at 45 nm was measured, and the tyrosinase inhibition rate (%) was calculated according to formula 1.
  • the sample concentration was 5 mg zml (water dilution).
  • Inhibition rate (%) B 1-(S-S ⁇ B 1) / B 1 X 1 0 0-. '(Equation 1) [S OD like activity; active oxygen scavenging effect]
  • tyrosinase is triggered by active oxygen generated by ultraviolet light and is produced in cells called melanosite present in the basal layer of the skin. Be That is, in addition to the inhibition of tyrosinase, if it is possible to effectively suppress the active oxygen causing the activity of tyrosinase, it is considered that a whitening effect can be expected.
  • the reactive oxygen inhibition effect was measured according to a standard operation method using S O D A c t i t i d i d t e i t i t i o i K i t (manufactured by Wako Pure Chemical Industries, Ltd.). That is, a coloring reagent (containing 0.5 ⁇ m of xanthine and 0.42 ⁇ m of nitro bluet triazolium) in 10 ⁇ l of a sample solution dissolved in distilled water containing a 20% aqueous solution of DM SO. 1 phosphate buffer ( ⁇ ⁇ 8. 0)) 0. lm L was added and stirred for 1 minute.
  • an enzyme suspension (a suspension of 0.10 4 9 U ml of Xanthine Oxidase (derived from Buttermilk) in 0.1 M phosphate buffer (pH 8. 0)) 0.1 m
  • the mixture was allowed to react for 28 minutes in a 37 ° C constant temperature bath, and then the reaction stopping solution (69 O mM sodium dodecyl sulfate, 20 L) was added rapidly and stirred for 5 minutes (S ).
  • the concentration of the sample was 100 ⁇ g / mL (water dilution).
  • Reactive oxygen inhibition rate (%) (B 1-B 1 ⁇ B 1)-(S-S ⁇ B 1) / (B 1-B 1 ⁇ B 1) X 1 0 0 ⁇ ⁇ ⁇ ⁇ (Equation 2)
  • the enzyme activity is N-acetyl hexoside produced by hydrolysis of hyaluronic acid.
  • the increase in reducing power of tetrasaccharides having a reducing end with samin was measured by colorimetric determination with absorbance at 585 nm (Goery Journal, 31: 23-3237, 19) 9 0).
  • ⁇ P-DA reagent 10 g of p-DAB, 2.5 m 1 of 10 N hydrochloric acid solution, and 8 7.5 m 1 of acetic acid were mixed and diluted 10-fold with acetic acid immediately before use.
  • sample solution 200 ⁇ l diluted with water was mixed with 5 mg 1 and hyaluronidase 100 / il (40 0 n i t s) mixed and cultured at 37 ° C. for 20 minutes.
  • Reaction solution 1401 and p-DAB solution 600 AZ 1 were mixed and incubated at 37 ° C. for 20 minutes. 7) Absorbance at 585 nm was measured.
  • the measurement samples of S amp 1 e, C ontro 1, S-B lank and C-B lank prepared according to Table 1 below are prepared and their respective absorbances are measured, and the hyaluronidase inhibition rate (inhibition from Activity) was calculated.
  • the X mark indicates that the above-mentioned acetate buffer was used instead of the solution in the left column.
  • Hyalid nidase inhibition rate (%) (C-C-B L)-(S-S-B L) / (S-S-B L) X I O O- ⁇ '(Equation 3)
  • Table 2 The measurement results of the tyrosinase inhibition rate, the S OD-like activity, and the hyaluronidase inhibition rate measured as described above are shown in Table 2 below. As a comparative example, measurement results of extracts obtained by similarly extracting the leaves of Niugori are also shown. Table 2 Sample Tyrosinase inhibition rate (%) SOD-like activity (3 ⁇ 4) Hyaluronidase inhibition rate (%) Strawberry leaf 81.1 99.5 97.0
  • Examples (Extract samples 1 and 2) have extremely high values of tyrosinase inhibition rate, SOD-like activity, and hyaluronidase inhibition rate.
  • the comparative example hardly inhibits the hyaluronidase inhibition rate, and has a significantly low value for the tyrosinase inhibition rate and the SOD-like activity.
  • Extract sample 1 (leaf) was prepared at 200 c c and mixed and diluted in 400 c c glycerol to prepare a cosmetic.
  • Paneler 2 (woman of 65 years old): The stain of about 10 yen hardening has broken. In addition, it has very high moisturizing properties and fine-grained skin, and there is more than double the extension of the foundation.
  • Paneler 3 (a woman of 64 years old): The overall age spots became pale, and it was said that the skin became white. I have no experience so far It is moisturizing.
  • Paneler 4 (40-year-old woman): Although it is dry skin, after using the sample products, it became possible to feel a sense of security without taking any care. In addition, the number of blowouts due to the quality of allergies has decreased.
  • Paneler 5 (36-year-old woman): It was felt that the pores became large and cosmetic makeup was bad after one use. Moreover, I was getting darker around my eyes.
  • Paneler 6 (34-year-old woman): I found that the difference in cosmetic makeup was clear when used only once. Things like Kusumi in the whole face have disappeared. In addition, after being well moisturized, I have not been doing anything until now.
  • Paneler 7 (Male, 51 years old): Some buckwheat have become thinner and smaller. I noticed in about 10 days.
  • Paneler 8 (65-year-old man): The skin was oily and bothersome, but the sample became used and the oiliness was improved and nothing bothered. In addition, when the remaining sample is used only in the left hand, it becomes white, and I am surprised that the difference between the right hand and the color is clearly seen.
  • the cosmetic composition of the present invention is very moisturizing, and is effective in decolorization, reduction, and elimination of Shiva, etc. Also, many of the participants commented that most of the participants said, "The skin seems to have revived.” Also, there was no such thing as side effects such as itching or irritation.
  • the sample (87. 6 g) crushed by hand with a finger and crushed to several mm to several cm is mixed with 50% aqueous ethanol solution (1.8 1) Immersed in 1) and extracted at room temperature for 3 days. After the obtained extract was filtered, the above sample was added to a solution to which the same amount of 50% aqueous ethanol solution was added again, and extraction was performed for 3 days at normal temperature. The extracts after filtration were combined and concentrated under reduced pressure until the volume became 50 cc to obtain a solution solution of 50% ethanol extract of Dutch strawberry leaves.
  • the enzyme solution (mushroom-derived tyrosinase 30 U, manufactured by SIGMA, 2 ⁇ M) was mixed well and subjected to enzyme reaction in a thermostat at 37 ° C. for 15 minutes. After that, 0.1 NHCL aqueous solution (20 ⁇ l) was added as a reaction stop solution (S).
  • S reaction stop solution
  • the above-described extract sample solution showed 81. 1% tyrosinase inhibitory activity.
  • the above extract (about 20. 4 g) is liquid-liquid partitioned between water and ethyl acetate to obtain a water fraction (about 11. 4 g) and an ethyl acetate fraction (about 2.6 g).
  • the water fraction showed 79.5% tyrosinase inhibitory activity, which was higher than 47.8% of the ethyl acetate fraction.
  • the above water fraction was fractionated with DI ANON HP-20 column chromatography, and the water fraction (about 3.9 g), the fraction eluted with 25% methanol aqueous solution (about 1. 9 g), 50% methanol aqueous solution elution fraction (about 1.3 g), The fraction eluted with 75% aqueous methanol solution (about 134.0 mg) and the fraction eluted with methanol (about 33.9 mg) were obtained.
  • the respective tyrosinase inhibitory activity was 20. 1% in water fraction, 87.8% in 25% methanol aqueous solution eluted fraction,
  • the fraction eluted with 50% methanol aqueous solution is 75.5%, the fraction eluted with 75% methanol aqueous solution is 55.1%, and the fraction eluted with methanol is 18.2%,
  • Dissolution solvent 18% acetonitrile
  • UV detector 2 5 4 n m, 3 3 0 n m
  • Reactive oxygen suppression effect is S OD A ctivity D etection It measured according to the standard procedure using Kit (made by Wako Pure Chemical Industries, Ltd.). That is, the color reagent (Xanthine 0.4 M and NitroBluete trazolium 0.24 ⁇ m contained) in 10 ⁇ L of the sample solution dissolved in distilled water containing 20% aqueous DM 2 SO 4. 1 M phosphate buffer ( ⁇ ⁇ 8. 0)) 0. lm L was added and stirred for 1 minute. Enzyme suspension (Xanthine oxidase (derived from Buttermilk) 0. OS UZmL suspended in 0. IM acid buffer (pH 800) 0. 1 ml added to 0.
  • Kit made by Wako Pure Chemical Industries, Ltd.
  • Reactive oxygen inhibition rate (%) (B 1-B 1 ⁇ B 1)-(S-S ⁇ B 1) / (B 1-B 1 ⁇ B 1) X 1 0 0 ⁇ ⁇ ⁇ ⁇ (Equation 5)
  • F r. 2, F r. 3 and F r. 4 are respectively C ompound 1, C ompound 2 and C ompound 3, mass spectrometry (F AB-MS), nuclear magnetic resonance spectroscopy ( Structural analysis was performed by NMR) and the like.
  • F AB-MS mass spectrometry
  • NMR nuclear magnetic resonance spectroscopy
  • C o m p o u n d 3 was identified as q u e r c e t i n-3-o-D-g 1 u c u r o n i d e.
  • the structure is shown in Fig.3.
  • C o m p o u n d 1 is a compound obtained by adding a sugar having 4 ash to C o m o p o u n d 3 (q u e r c e t i n-3-o _ D-g 1 u c u r o n i d e).
  • the estimated structure of Com po u n d 1 is shown in Fig.5.
  • C ompound 2 is a compound having many hydroxyl groups. Further, the 13 C-NMR spectrum of C ompound 2 shown in FIG. 7 is very similar to the 13 C- NMR spectrum of C asuarictin shown in FIG. 8. Figure 9 shows the structural formula of Casuarictin.
  • C ompound 3 is very likely to be a hydrolyzable derivative of tannic acid, and 4 to 5 gallic acid esters are present around a sugar having 6 carbons such as C asuarictin. It can be inferred that the structure has something like a bond. However, because the carbon number of C o m p o u n d 2 is as large as 66, it is suggested that the two types of compounds may be mixed as an isomer.
  • Compo n d 2 exhibited high tyrosinase inhibitory activity as compared to the activity indicator substance, albumin.
  • C o m p o u n d 1 and 3 showed an S OD-like activity almost similar to that of the activity indicator (+)-force tekin. From the above results, it can be said that C o m p o u n d 1 to 3 are physiologically active substances contained in strawberry leaves.
  • Paneler 2 (Housewife 4 and 7 years old): My hobby is gardening, but when pollen was about to fly, I was plagued by hay fever. "If I apply it to the nasal cavity,” I have a strawberry leaf extract, and if I apply it with a cotton swab, I get a squeeze once and only blow my nose. I could do gardening comfortably until the evening.
  • Paneler 3 (Housewife 3 to 8 years old): Every time I washed the laundry out because of hay fever, I had a hard time thinking. I applied the strawberry leaf extract and was convinced that if it was a strawberry, I applied it to the nasal cavity with a cotton swab, and I was happy because the bad runny nose stopped and it worked for a long time. I can not let go.
  • Paneler 4 (Instructor 2 6 years old): I went to work by bicycle, but my nose was blocked, sore, and my runny nose stopped working. It was in the state where I could not do makeup. One day, I applied it to my nasal cavity and got a sample of fig leaf extract, and I used it immediately, and I had a runny nose, sneezing, and a bitter stuffy nose. Please sell products that are effective against rhinitis so quickly.
  • Paneler 5 A full-time housewife 5 4 years old: I really appreciate the strawberry leaf extract. I went to the doctor and gave me various medicines, but I also had problems with my stomach and getting concerned. The strawberry leaf extract smells better, and I prefer house dust than hay fever, but the mucous membranes become loose and exfoliate, nosebleeds, stuffy nose, and runny nose does not stop. Was in the middle of the year. Because of that, thanks to the strawberry leaf extract, the mucous membranes are normal, the nose is not clogged, and the nasal discharge is not much. A quick product for many suffering people.
  • Paneler 6 (unemployed old man 7 2 years old): I go to the pool every day, Even if you get older, you suddenly have hay fever. At first I went to the doctor's office thinking that I had a cold, and I was diagnosed with hay fever. I thought this age, but I got a medicine from a doctor, but it didn't work very well. A clerk from the pool told me, “I put a strawberry leaf extract on a cotton swab and applied it to the nose hole”. After about 15 minutes of painting, the runny nose and sneezing stopped. If it is good, I will have you kindly when I raise a sample. I am now happy to be in the pool. It has immediate effect, and it smells good even if it's painted in the nose, so I spend my time in good mood. Please make it a product soon.
  • Paneler 7 (38-year-old housewife): Even though I took measures against pollinosis such as injection for a month or more and burning the mucous membranes of the nose in anticipation of flying pollen, the painful symptoms did not change from the previous year. The When I applied the strawberry leaf extract to the back of my nose with a cotton swab, it became very easy. As conventional medicines cause stomach upset and side effects such as having to take stomach medicines appear, I would like you to use strawberry leaf extract as a product.
  • Paneler 8 (64-year-old housewife): Pollinosis history 20 years. If this time was this, I gave up, but when I applied the strawberry leaf extract to the back of the nasal cavity, in the moment Kushami went out five times in a row, and it became very easy from now on, when I had a runny nose. I can breathe suussu with my nose. Also, it was easier for my eyes to be crushing. In the past, it was difficult to make the nasal mucous membrane a power subta, and when I took it I got nosebleed, and then I made a physical subta and repeated it, but the strawberry leaf extract was repeated 3 times a day. I have been able to spend an easy day by painting four times.
  • Hay fever is the most important nose to breathe, so I thought that I would be glad if I could apply for this medicine, because I had been suffering for many years.
  • it was very easy with strawberry leaves.
  • it acts on the mucous membrane to exert excellent anti-allergic and antihistamine actions, and in particular it acts on the nasal mucous membrane to alleviate the symptoms of so-called pollinosis such as runny nose and mucilage, etc.
  • It can be used as an external preparation for mucous membranes such as mucous membranes.
  • therapeutic and alleviating effects such as allergic dermatitis can be expected.
  • the external preparation for skin of the present invention has a high tyrosinase activity inhibitory action and also an antibacterial activity, it is an external preparation for skin care intended for the prevention of acne and stains and treatment including skin lightening cosmetics. Can be used. It can also be used as an external preparation for mucous membranes such as nasal mucous membranes.

Abstract

It is intended to provide an external preparation for skin capable of obtaining an effect of making the skin more beautiful by exhibiting an effect of removal of active oxygen, moisturization, prevention of inflammation, antiallergy or skin aging or the like as well as having a whitening effect; and an external preparation for mucosa exhibiting an excellent antiallergic action and antihistaminic action by acting on the mucosa. The external preparation for skin contains an extract of leaves and/or stems of a plant belonging to the genus Fragaria in the Rosaceae family as an active ingredient. The external preparation for skin is capable of obtaining an effect of making the skin more beautiful by exhibiting an effect of removal of active oxygen, moisturization, prevention of inflammation, antiallergy or skin aging or the like as well as has a whitening effect which enables the restoration of the original color and gloss of the skin by reducing, fading or eliminating pigmentation or freckles accompanying aging. Further, the external preparation for mucosa exhibits an excellent antiallergic action and antihistaminic action by acting on the mucosa, and is particularly capable of alleviating the symptoms of so-called hayfever such as a runny nose or sneezing by acting on the nasal mucosa.

Description

皮膚外用剤および粘膜外用剤 技術分野  Skin external preparation and mucosal external preparation
本発明は、 皮膚に塗ったり、 染みこませたり、 擦ったり、 接触させた りすることによって経皮的に皮膚内部へ浸透させ、 既にできたシミ、 ソ バカス等を低減、 退色させて、明本来の皮膚の色を取り戻すために用いら れる皮膚外用剤に関し、 主と して化粧水、 化粧ク リーム等の基礎化粧品 や入浴剤、 薬用石けん等と して用いるこ書とができる皮膚外用剤、 および 粘膜に作用して優れた抗ァレルギ一作用、 抗ヒスタミン作用を発揮する 粘膜外用剤に関するものである。 背景技術  The present invention allows the skin to penetrate the inside of the skin percutaneously by applying, immersing, rubbing or contacting the skin, thereby reducing or fading the stains and soaks that have already been formed. With regard to external preparations for skin used to restore the original color of the skin, external preparations for external use for skin can be used mainly as basic cosmetics such as lotions, cosmetic creams, bath preparations, soaps for medicinal use, etc. The present invention relates to an external preparation for mucous membrane which exerts an excellent antiallergic action and an antihistamine action by acting on mucous membranes. Background art
近年の成層圏オゾン層の破壌に基づいて増加する紫外線から肌を守り、 皮膚の老化、 黒化を防止するとともに、 シミ、 ソバカス、 くすみをなく して皮膚本来の美しさを取り戻すことを目的と した美白用基礎化粧品の 需要が高まっている。 特に、 1 9 9 0年代に流行した顔黒のために、 紫 外線を照射して日焼けさせた女性たちが、 美白化の流行に転換するよう になり、 日焼けがおさまった後に残ったシミ、 ソバカスを取り除く こと について、 強い要望がある。  It aims to protect the skin from ultraviolet rays that increase based on the stratospheric ozone layer damage in recent years, prevent skin aging and blackening, eliminate stains, buckwheat, and dullness, and restore the skin's original beauty. Demand for basic cosmetics for whitening is increasing. In particular, women who were exposed to ultraviolet rays and tanned because of the face black that was popular in the 1990s began to shift to the trend of whitening, and stains that were left after the tanning was sunk, buckwheat There is a strong demand for removing
美白用化粧品と しては、 紫外線照射により生じる活性酸素による色素 産生を抑制して、 肌の老化に伴う くすみを改善しよう とするものや、 シ ミの原因となるメラニン生成反応の一部を触媒するチロシナーゼ活性を 阻害することによ り シミを低減しよう とするものがある。 前者の化粧品 と しては、 ビタミン C、 トコフエロール (ビタミン E )、 スーパーォキシ ドジスムターゼ (S O D ) 等の抗酸化剤を含有させた化粧品が販売され ている。 しかし、 ビタミン C、 E等のビタ ミン類は、 一般に安定性が悪 く、 また活性酸素で酸化された後に生じる酸化型ビタ ミ ン A、 酸化型ビ タミ ン Eが悪影響を及ぼすため、 美白という点では満足できるものでは ない。 安定性に優れた合成抗酸化剤は、 近年の消費者の安全性志向、 自 然志向、 健康志向から、 敬遠される傾向にある。 As cosmetics for whitening, products that suppress pigment production due to active oxygen generated by ultraviolet irradiation and try to improve the dullness associated with aging of the skin, or catalyze some of the melanogenesis reaction that causes the skin. Some attempts to reduce stains by inhibiting the tyrosinase activity. As the former cosmetics, vitamin C, tocopherol (vitamin E), superoxy Cosmetics containing antioxidants such as dodismutase (SOD) are on the market. However, vitamins such as vitamins C and E are generally unstable, and have an adverse effect on oxidized vitamin A and oxidized vitamin E that are produced after oxidation with active oxygen. It is not satisfactory in terms of points. Synthetic antioxidants with excellent stability tend to be reluctant from recent consumer safety, natural and health concerns.
このよ うな状況のもと、 自然派化粧品を好む消費者の要望に応えるベ く、 美肌、 美白化に有用な成分と して、 ハーブエキス又は生薬エキスを 使用した美白用自然派化粧品が提案されている。  Under these circumstances, natural cosmetics for whitening using herbal extract or herbal extract as a component useful for skin care and whitening should be proposed to meet the needs of consumers who prefer natural cosmetics. ing.
例えば、 特許文献 1には、 チロシナーゼ活性阻害に基づく メラニン生 成抑制剤と して、 ゥコン、 チヨ ウジ等の生薬抽出物を含有する皮膚化粧 料が開示されている。 ここで用いられるゥコン抽出物は、 ゥコンの根茎 部を水、 メタノール、 エタノール等の親水性有機溶剤で抽出した抽出物 である。  For example, Patent Document 1 discloses, as a melanin production inhibitor based on the inhibition of tyrosinase activity, a skin cosmetic containing a herbal extract such as curcuma versifolium and cucumber. The cucon extract used herein is an extract obtained by extracting the rhizome of cucon with a hydrophilic organic solvent such as water, methanol, or ethanol.
特許文献 2には、 バンゥコン、 ササゲ、 ヮサビノキ等の生薬抽出物が 不飽和脂肪酸酸化防止作用及び活性酸素消去作用に優れ、 これらを含有 する皮膚外用剤がくすみ改善に対してビタミ ン Eより も優れていること が開示されている。 ここで用いられているバンゥコンの抽出物は、 地下 茎の熱水抽出物、 全草のエタノール抽出物、 地下茎の 1, 3 _ブチレン グリ コールの抽出物であり、 当該抽出物の優れた抗酸化作用によ り、 シ ヮ、 ノ、リ、 さらには肌のくすみを改善しょ う とするものである。  In Patent Document 2, crude drug extracts such as banshu, cowpea, and persimmon are excellent in the antioxidant action against unsaturated fatty acid and active oxygen scavenging action, and the external preparation for skin containing these is superior to vitamin E for the improvement of blur. Is disclosed. The extract of Bankon used in this case is a hot water extract of the rhizome, an ethanol extract of whole grass, an extract of 1, 3-butylene glycol of the rhizome, and the excellent antioxidant of the extract By action, it is intended to improve skin, skin, skin and dullness.
特許文献 3には、 グリセリ ンやヒアルロン酸 N a等の水溶性増粘剤、 エタノ一ル等の抗菌性アルコール、 トコフエロール類等の抗酸化ビタミ ン類、 メフユナム酸やトラネキサム酸等の抗炎症剤とともに、 美白成分 と して、 ォゥゴン、 ボタン、 アロエ、 にんじん、 ゥコン等の植物抽出物 を添加した化粧用組成物が開示されている。 特許文献 1 特開平 6 - 2 2 7 9 6 0 Patent Document 3 discloses water-soluble thickeners such as glycerol and hyaluronic acid Na, antibacterial alcohols such as ethanol, antioxidant vitamins such as tocopherols, and anti-inflammatory agents such as mefenamic acid and tranexamic acid. There is also disclosed a cosmetic composition to which a botan extract, a button, an aloe, a carrot, a plant extract such as curcuma has been added as a whitening component. Patent Document 1 Japanese Patent Application Laid-Open No. 6-2 2 7 9 6 0
特許文献 2 特開 2 0 0 2— 1 2 1 1 4 4  Patent Document 2 Japanese Patent Application Laid-Open No. 200002 1 2 1 1 4 4
特許文献 3 特開 2 0 0 2— 2 1 2 0 5 2 発明の開示  Patent Document 3 Japanese Patent Application Laid-Open Publication No. 200002-2 0 1 2 0 5 2
発明が解決しょ う とする課題 Problems that Invention is to Solve
抗酸化成分による活性酸素の捕捉は、 紫外線照射によるシミ、 ソバカ スの新生を抑制しょう とするものであり、 既にできているシミ、 ソバカ スの低減、 消失、 退色といった美白効果に対しては、 更なる向上が望ま れている。 また、 美白効果だけでなく、 お肌の潤いを保っための保湿効 果ゃ、 炎症 ·抗ァレルギ一症 ·皮膚老化の予防や抑制に効果を発揮する ものであれば一層の美肌効果が得られ、 このよ うな皮膚外用剤の開発が 強く望まれている。  The scavenging of reactive oxygen species by the antioxidant component is intended to suppress the formation of stains and sorrows by ultraviolet irradiation, and against the whitening effects such as reduction, disappearance, and fading of stains and sorrows that have already been formed, Further improvement is desired. In addition to skin lightening effects, it also has a moisturizing effect to keep the skin moist, inflammation, anti-allergy, and skin lightening effects as long as it is effective in preventing and suppressing skin aging. There is a strong demand for development of such external skin preparations.
一方、 近年は、 ア ト ピー性皮膚炎や花粉症等の各種アレルギー性疾患 患者が増加しており、 その治療が社会的な問題になっている。 しかしな がら、 現在のところ対症療法に頼るところが大きく、 ァレルギ一疾患の 根本的治療につながる優れた治療薬が切望されながら、 その開発は今尚 暗中模索の域にあると言わざるを得ない。 最近は、 抗ヒスタ ミ ン薬や、 S R S _ Aの産生を抑えるかそれに拮抗する薬剤が種々開発されてきて いるが、 副作用の面で十分とは言えず、 副作用の少ない天然物由来の治 療物質の開発が強く望まれている。  On the other hand, in recent years, patients with various allergic diseases such as atopic dermatitis and hay fever have been increasing, and their treatment has become a social problem. However, at present, much reliance on symptomatic treatment is required, and it is necessary to say that its development is still in the midst of groping, while excellent therapeutic agents leading to the fundamental treatment of arelarrhei are in great demand. Recently, various anti-histamine drugs and drugs that reduce or antagonize the production of SRS_A have been developed, but are not sufficient in terms of side effects, and treatment with natural products with fewer side effects Development of substances is strongly desired.
本発明は、 このような事情に鑑みてなされたものであり、 紫外線照射 による 日焼けをはじめ、 老化に伴うシミ ' ソバカスの低減、 退色 ' 消去 により皮膚本来の色 · 艷をよみがえらせる美白効果を有すると ともに、 活性酸素の除去、 保湿、 炎症 ·抗ァレルギ一症 ·皮膚老化の予防等に効 果を発揮して一層の美肌効果を得られ、 高い抗ァレルギ一作用によりァ レルギ一性の皮膚炎等の治療や緩和効果も期待できる皮膚外用剤、 およ び粘膜に作用して優れた抗ァレルギ一作用、 抗ヒスタミン作用を発揮す る粘膜外用剤を提供することをその目的とする。 課題を解決するための手段 The present invention has been made in view of these circumstances, and it has a skin-whitening effect to rejuvenate the skin's original color and wrinkles by reducing sunburn due to ultraviolet irradiation, reducing stains due to aging and fading off. At the same time, it is effective in removing active oxygen, moisturizing, inflammation, anti-allergy, prevention of skin aging, etc., and it is possible to obtain a more beautiful skin effect. An external preparation for skin which can be expected to treat or alleviate eryrgic dermatitis and the like, and an external preparation for mucous membrane which exerts an excellent antiallergic action and an antihistaminic action by acting on mucous membranes To aim. Means to solve the problem
本発明の皮膚外用剤は、 バラ科オランダイチゴ属植物の葉および Zま たは茎のエキスを有効成分と して含有することを要旨とする。  The external preparation for skin of the present invention is characterized in that it contains an extract of leaves and Z or a stem of a plant belonging to the genus Rosaceae of the family Rosaceae as an active ingredient.
本発明の粘膜外用剤は、 バラ科オランダイチゴ属植物の葉および ま たは茎のエキスを有効成分と して含有することを要旨とする。 発明の効果  The external preparation for mucous membrane of the present invention is characterized by containing extracts of leaves and stems of a plant belonging to the genus Rosaceae of the family Rosaceae as active ingredients. Effect of the invention
本発明の皮膚外用剤は、 経皮的に皮膚内部に取り込まれて、 チロシナ ーゼの活性を阻害することにより、 シミの原因となるメ ラニンの生成を 抑制し、 さらに皮膚のターンオーバーに伴って、 すでにできたシミ、 ソ バカスを退色、 低減を期待できるので、 化粧料、 入浴剤に配合される美 白エッセンスと して有効である。 また、 本発明の皮膚外用剤は、 チロシ ナーゼ阻害活性効果と ともに、 優れた S O D様活性値を示すことから活 性酸素消去効果をも発揮する。 さらに、 本発明の皮膚外用剤は、 チロシ ナーゼ阻害活性効果および活性酸素消去効果と ともに、 優れたヒアルロ ニダーゼ阻害率値を示すことからお肌の潤いを保っための保湿効果や、 炎症 · 抗ァレルギ一症 · 皮膚老化の予防や抑制に効果を発揮するもので あれば一層の美肌効果が得られる。 また、 優れた抗ア レルギー作用によ りァレルギ一性の皮膚炎等の治療や緩和効果も期待できる。  The external preparation for skin of the present invention is percutaneously incorporated into the skin to inhibit the activity of tyrosinase, thereby suppressing the formation of melanin which is a cause of the stain, and further along with the turnover of the skin. Since it can be expected to reduce stains and stains that have already been made, it is effective as a whitening essence to be added to cosmetics and bath agents. In addition to the tyrosinase inhibitory activity effect, the external preparation for skin of the present invention also exhibits an active oxygen scavenging effect because it exhibits an excellent SOD-like activity value. Furthermore, the external preparation for skin of the present invention exhibits excellent hyaluronidase inhibition value together with tyrosinase inhibitory activity effect and active oxygen scavenging effect, and thus a moisturizing effect for keeping the skin moist, inflammation, anti-allergy One symptom · A more beautiful skin effect can be obtained if it is effective in preventing and suppressing skin aging. In addition, due to its excellent anti-allergic action, it can also be expected to have a therapeutic or alleviating effect on allergies such as dermatitis.
本発明の粘膜外用剤は、 粘膜に作用して優れた抗アレルギー作用、 抗 ヒスタ ミン作用を発揮し、 特に鼻粘膜に作用して鼻水やクシャミ等のい わゆる花粉症の症状を緩和することができる。 図面の簡単な説明 The external preparation for mucous membrane of the present invention acts on the mucous membrane to exert an excellent anti-allergic action and anti-histamine action, and in particular, acts on the nasal mucous membrane to alleviate the symptoms of so-called pollinosis such as runny nose and sores. Can. Brief description of the drawings
図 1 イチゴ葉抽出物の分画およびチロシナーゼ阻害活性の測定結果を 示す図。 Fig. 1 Fraction of strawberry leaf extract and measurement results of tyrosinase inhibitory activity.
図 2 C o m p o u n d 3の 1 H— NMRスペク トルである。 Fig. 2 1 H NMR spectrum of C ompound 3.
図 3 q u e r c e t i n— 3— o — D— g l. u c u r o n i. d eの構 造式を示す。 Figure 3 shows the structural formula of q u e r c t i n — 3 — o — D — g l. U c u r o n i. D e.
図 4 C o m p o u n d 1の 1 H— NMRスペク トルである。 Fig. 4 1 H NMR spectrum of C ompound 1.
図 5 C o m p o u n d 1の推定構造を示す。 Figure 5 shows the estimated structure of C o m p o u n d 1
図 6 C o m p o u n d 2の 1 H— N M Rスぺク トノレである Figure 6 1 H NMR spectrum of C ompound 2
図 7 C o m p o u n d 2の 1 3 C— NMRスぺク トノレである。 A 1 3 C-NMR spectrum Honoré in FIG 7 C ompound 2.
図 8 C a s u a r i c t i nの 1 3 C— NMRのスぺク トルである。 図 9 C a s u a r i c t i nの構造式を示す。 発明を実施するための最良の形態 Fig. 8 Spectrum of 13 C- NMR of Casuarictin. Figure 9 shows the structural formula of C asuarictin. BEST MODE FOR CARRYING OUT THE INVENTION
本発明の皮膚用外用剤は、 バラ科オランダイチゴ属植物の葉および Z または茎のエキスを有効成分と して含有する。  The external preparation for skin of the present invention contains the extract of leaves and Z or stems of a Rosaceae L. plant as a active ingredient.
本発明に用いるバラ科オランダイチゴ属植物と しては、 いわゆる食用 と して栽培きれているオランダイチゴであれば备種の品種のものを用い ることができる。 例えば、 とよのか、 女峰 (にょほう)、 とちおとめ、 章 姫 (あきひめ)、 アイべリー、 とちひめ、 レツ ドパール、 さちの力 あま おう、 宝交早生、 紅ほっぺ等各種の品種の植物を用いることができる。 使用する植物と しては、 バラ科オランダイチゴ属に属するものである必 要があるが、 上述した品種に限定する趣旨ではない。  As the Rosaceae family Dutch strawberry plant used in the present invention, if it is a so-called edible Dutch strawberry, it is possible to use a variety of mulberry species. For example, Toyo Noka, Nyoho, Tochiotome, Chapter princess (Akihime), Iberly, Tochihime, Red pearl, Sachi's power Ama, Treasure early birth, Benihopope, etc. Plants can be used. The plant to be used needs to be a plant belonging to the genus Rosaceae, but not intended to be limited to the above-mentioned varieties.
バラ科オランダイチゴ属植物のエキスを抽出するために使用する抽出 溶媒と しては、 供する製品の使用目的、 種類あるいは後に行う加工処理 等を考慮した上で選択すれば良いが、 上記バラ科オランダイチゴ属植物 の葉および Zまたは茎のエキスは、 水および またはアルコールで抽出 した抽出物とするのが好ましい。 このようにすることにより、 美肌に有 効な成分を破壊することなく効果的に抽出できると考えられるからであ る。 As an extraction solvent used to extract an extract of the genus Rosaceae L. planta, the purpose of use of the product to be provided, type or processing to be performed later Although it may be selected in consideration of the etc., it is preferable to use the extract of leaves and Z or stem of the above-mentioned Rosaceae Lubifer plant as extract extracted with water and / or alcohol. By doing this, it is considered that it is possible to extract effectively without destroying the effective ingredients for the beautifying skin.
上記アルコールと しては、 メタノール、 エタノール、 プロ ピルアルコ ール、 イ ソプロ ピノレアルコール、 ブタノール等の低級アルコール ; プロ ピレンダリ コール、 1, 3 —ブチレングリ コーノレ、 グリセ リ ン等の多価 アルコール等を用いることができる。 これらは単独でもしくは併せて用 いることができる。  As the above-mentioned alcohol, lower alcohols such as methanol, ethanol, propyl alcohol, isopro pinole alcohol, butanol, etc .; polyhydric alcohols such as propylidene alcohol, 1, 3-butyleneglycolone, glycerin etc. are used. be able to. These can be used alone or in combination.
抽出に際しては、 例えばバラ科オランダイチゴ属植物の葉および ま たは茎を水で抽出した後メダノールで抽出するなど、 複数段階で抽出を 行ってもよいが、 美白成分の含有率を高めるために、 水とエタノールの 混合液による抽出工程を含むようにするこどが好ましい。  The extraction may be performed in multiple steps, for example, extraction with leaves of leaves and stems of the genus Rosaceae and the stem with water and then extraction with medanol, but in order to increase the content of the whitening component It is preferable to include an extraction step with a mixture of water and ethanol.
これらの溶媒で抽出したエキス含有溶液をそのまま皮膚外用剤と して 用いても良いし、 必要に応じて濃縮、 希釈、 濾過、 乾燥等の処理をして 用いても良い。 また、 抽出後、 アルコールを乾燥等により揮発させてし まって、 美白成分の含有率が高い粉末を得るようにしてもよい。  The extract-containing solution extracted with these solvents may be used as it is as a skin external preparation, or may be used after being subjected to processing such as concentration, dilution, filtration, drying and the like as necessary. In addition, after extraction, the alcohol may be volatilized by drying or the like to obtain a powder having a high content of the whitening component.
上記バラ科オランダイチゴ属植物の葉おょぴ Zまたは茎は、 食用果実 と して栽培されている植物であれば使用することができるが、 果実収穫 後の葉および Zまたは苤を採取して使用するのが好ましい。 従来廃棄し ていた果実収穫後の葉および または茎を有効利用してリサィクル面か ら好ましいからである。  The leaves and stems of the above-mentioned Rosaceae Lubiferus plants can be used as long as the plants are grown as edible fruits. It is preferred to use. This is because leaves and / or stems after fruit harvest which have been conventionally discarded are effectively used from the viewpoint of recycling.
上記バラ科オランダイチゴ属植物の葉および Zまたは茎は、 栽培され ているものを採取してその状態のまま水および Zまたはアルコールで抽 出することもできる力 採取後自然乾燥もしく は人工的に乾燥したのち、 水および またはアルコールで抽出することが好ましい。 このよ うにす ることによ り、 乾燥によって濃縮されたエキスを抽出することができる と考えられるからである。 また、 乾燥することにより、 葉およびノまた は茎の状態が安定し、 状態のばらつきが少なくなって抽出されるエキス の品質も安定化するとともに、 葉および Zまたは茎の保存性もよくなつ て取扱い性が格段に向上するからである。 The leaves and Z or stalks of the above-mentioned Rosaceae L. plant are collected and can be extracted with water and Z or alcohol as they are. Forced after extraction, natural drying or artificial After being dried Extraction with water and / or alcohol is preferred. By doing this, it is considered that the extract concentrated by drying can be extracted. In addition, drying stabilizes the condition of leaves and green leaves or stems, reduces variations in conditions, stabilizes the quality of the extract to be extracted, and improves the shelf life of leaves and Z or stems. This is because the handling is significantly improved.
また、抽出方法は、水のみまたはアルコールのみで抽出してもよいし、 水とアルコールの混合液で抽出してもよい。 また、 加熱抽出することも できるが、 常温で抽出するのが好ましい。 加熱によるエキスの破壌が少 なくなり、 美肌に有効な成分が効果的に抽出されると考えられるからで ある。  Also, the extraction method may be extraction with water only or alcohol only, or extraction with a mixture of water and alcohol. It can also be extracted by heating, but extraction at normal temperature is preferred. It is because it is thought that the breakage of the extract due to heating is reduced and the effective ingredient for the beautifying skin is effectively extracted.
本発明の皮膚外用剤は、 上記バラ科オランダイチゴ属植物の葉および Zまたは茎のエキスを適当な溶媒、基剤に含有させて使用してもよいし、 上記エキスをエッセンスと して、化粧品や医薬部外品に添加してもよレ、。 具体的には、 美白料だけでなく、 ク レンジングク リーム、 ク レンジング ローショ ン、 洗顔ク リーム、 石けん等の皮膚洗浄剤 ; 保湿化粧水、 柔軟 化粧水、 収斂化粧水等の整肌料 ; ミルキイローション、 ェモリエントミ ルク、 バニシングク リーム等の保護料 ; マッサージク リーム、 マッサ一 ジローショ ン、 フォームパック、 ピールオフパック等の賦活料;入浴剤 ; パップ剤などに、 美白成分と して添加してもよい。 いずれの場合も、 経 皮的に有効成分が皮膚内部に取り込まれて、 シミ、 ソバカスの退色、 低 減、 消失に働く ことができる。  The external preparation for skin of the present invention may be used by adding the extract of leaves and Z of stem or sock of the Rosaceae family to an appropriate solvent and base, or the extract as an essence, and cosmetics. Or add it to quasi-drugs. More specifically, skin cleansing agents such as cleansing creams, cleansing lotions, facial cleansing creams, soaps, etc. as well as whitening agents; moisturizing lotions, soft lotions, skin conditioning agents such as astringent lotions; Milky lotions Protection agents such as emollient milk and vanishing cream; activators such as massage cream, massage system, foam pack, peel off pack etc .; bath additives; and whitening agents may be added as whitening ingredients. In any case, the active ingredient is incorporated into the skin and can be used to cause stains and buckwheat discoloration, reduction and disappearance.
最終製品におけるバラ科オランダイチゴ属植物の葉および Zまたは茎 のエキスの含有割合は、 最終製品の種類に応じて適宜選択されるが、 化 粧料の場合、 1〜 8 0質量%程度が好ましい。  The content ratio of leaf and Z or stem extract of Rosaceae L. plant in the final product is appropriately selected according to the type of final product, but in the case of cosmetics, about 1 to 80 mass% is preferable .
本発明の皮膚外用剤は、 最終製品に応じて、 抽出物の効果を損ねない 範囲で、 基剤、 保湿剤、 増粘剤、 界面活性剤類、 p H調整剤、 防腐剤、 香料、 保湿剤、 紫外線吸収剤、 増粘剤、 色素、 酸化防止剤、 キレート成 分を配合することができる。 The external preparation for skin of the present invention does not impair the effect of the extract depending on the final product. In the range, base, moisturizer, thickener, surfactant, pH adjustment agent, preservative, fragrance, moisturizer, UV absorber, thickener, pigment, antioxidant, chelate component can do.
油性基剤と しては、 ミツロウ、 カカオ油;カルナバロゥ、 高級脂肪酸、 固形パラフィン、 セチルアルコール、 ステアリルアルコール等の固形状 油性原料 ; ワセリ ン、 ラノ リ ン等の半固形状油性原料 ; スクヮラン、 ォ リーブ油、 ヒマシ油、 パーム油、 ピーナッツ油、 流動パラフィン、 ォレ イン酸、 リ ノール酸、 ミ リスチン酸ォクチルドデシル、 シリ コーン油な どを用いることができる。  As the oil base, solid oily raw materials such as beeswax, cacao oil; carnaval roux, higher fatty acids, solid paraffin, cetyl alcohol, stearyl alcohol etc .; semi-solid oily raw materials such as wa- seline, lanolin etc; Leave oil, castor oil, palm oil, peanut oil, liquid paraffin, oleic acid, linoleic acid, octoyldodecyl dodecyl myristate, silicone oil, etc. can be used.
水性基剤としては、 グリセリン、 ソルビトール、 ポリエチレングリ コ ール、 ピロ リ ドンカルボン酸及びその塩、 コラーゲン、 ヒアルロン酸及 びその塩、 コンドロイチン硫酸及びその塩等の保湿剤 ; カルボキシメチ ノレセ/レロースナト リ ウム、 ポリ ビニノレア/レコーノレ、 キサンタンガム、 力 ルボキシビニルポリマー、 ヒ ドロキシプロピルセルロース、 アラビアゴ ム等の増粘剤などが用いられる。  As the aqueous base, moisturizing agents such as glycerin, sorbitol, polyethylene glycol, pyrrolidone carboxylic acid and salts thereof, collagen, hyaluronic acid and salts thereof, chondroitin sulfate and salts thereof, and the like; And polyvinyl cinolea / leconole, xanthan gum, ruboxy vinyl polymer, hydroxy propyl cellulose, thickeners such as arabic gum, and the like are used.
界面活性剤と しては、 イソステアリ ン酸ポリエチレングリ コール、 ス テアリ ン酸ソルビタン、 グリセリ ン脂肪酸エステル、 ポリオキシェチレ ンへキシルデシルエーテル等の非イオン型界面活性剤 ; ラウリル硫酸ナ ト リ ウム、 ラウリルリン酸ナ トリ ゥム等のァニオン型界面活性剤 ;塩化 ステアリルジメチルベンジルアンモニゥム等のカチオン型界面活性剤 ; ショ糖脂肪酸エステル、 カゼインナト リ ウム、 レシチン、 コラーゲン等 の天然型界面活性剤などが用いられる。  As surfactants, non-ionic surfactants such as polyethylene glycol isostearylate, sorbitan stearate, glyceryl fatty acid ester, polyoxyethylene hexyl decyl ether, etc .; sodium lauryl sulfate, lauryl phosphate Anionic surfactants such as sodium phosphate; cationic surfactants such as stearyldimethylbenzyl ammonium; natural surfactants such as sucrose fatty acid ester, sodium caseinate, lecithin, collagen etc. Be
p H調整剤と しては、 炭酸力リ ゥム、 炭酸水素ナ ト リ ゥム、 炭酸水素 アンモニゥム等が挙げられる。  Examples of pH adjusters include carbonated lithium, sodium bicarbonate, ammonium bicarbonate and the like.
この他、 必要に応じて添加され得るものと して、 パラジメチルァミノ 安息香酸、 ゥロカニン酸ェチル、 ジイソプロピル桂皮酸ェチル、 2—ヒ ドロキシー 4ーメ トキシベンゾフエノ ン、 サリ チル酸 ト リエタノールァ ミ ン等の紫外線吸収剤 ; ェチルパラベン、 ブチルパラベン等の防腐剤 ; グリチルリチン酸誘導体、グリチルレチン酸誘導体、サリチル酸誘導体、 ヒ ノキチオール、 酸化亜鉛、 アラン トイン等の消炎剤 ; パルミチン酸レ チノール等のビタミン A類、 リボフラビン, ニコチン酸アミ ド等のビタ ミ ン B類、 コ レカルシフエロール等のビタ ミ ン D類、 d 1 — α— トコフ ェロール等のビタミン Ε類などの抗酸化剤;ェリ ソルビン酸ナ ト リ ウム、 セージエキス、 パラ ヒ ドロキシァ-ソール等の酸化防止剤 ; ローヤルゼ リー、 コ レステロール誘導体各種アミノ酸等の賦活剤 ; γ —オリザノー ル、 デキス トラン硫酸ナ ト リ ウム等の血行促進剤 ; チタンイェロー、 力 ーサミ ン、 ベニバナ等の色剤 ; その他の植物エキスが挙げられる。 実施例 Other than these, paradimethylamino benzoic acid, urocanic acid ethyl, diisopropyl cinnamic acid ethyl, and 2-hydric acid may be added as required. UV absorbers such as droxy 4-methoxybenzophenone and salicylate triethanolamine; preservatives such as cetylparaben and butylparaben; glycyrrhizinic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, Hinokitiol, zinc oxide, allan Anti-inflammatory agents such as toin etc. Vitamins A such as retinol palmitate, vitamins B such as riboflavin, nicotinic acid amide, vitamins D such as colecalciferol, d 1 − α-tocopherol etc. Antioxidants such as vitamins and cetaceans; antioxidants such as sodium sorbirate sodium, sage extract, parahydroxyl sole, etc .; active agents such as royal jelly, collesterol derivative various amino acids; γ — orizanol , Blood circulation enhancers such as sodium dextran sulfate; It includes other plant extracts; low force Sami down, colorant safflower like. Example
〔バラ科オランダイチゴ属植物のエキス試料の調製〕  [Preparation of an extract sample of a rose plant of the genus Rosaceae]
食用と して栽培されているオランダイチゴ (章姫およびとよのか) の 果実収穫後の葉および茎をそれぞれ採取し、 それぞれ自然乾燥させた後 手指で揉んで数 m m〜数 c m程度に砕いた試料 1 (葉部) および試料 2 After harvesting the leaves and stems of the harvested fruits of Dutch strawberry (Shohime and Tonooka) grown for food, they were naturally dried and crushed with a finger and crushed into several mm to several cm. Sample 1 (leaf) and sample 2
(茎部)を準備した。一方、抽出溶媒と して水 5 0 % +エタノール 5 0 % 溶液を準備した。 (Stem) was prepared. On the other hand, a 50% water + 50% ethanol solution was prepared as an extraction solvent.
上記抽出溶媒 1 リ ッ トルに上記各試料をそれぞれ 1 k g浸漬し、 常温 で 1 日間静置した後ろ過して一次抽出液を得た。 このよ うにして得た一 次抽出液にさらに 1 リ ツ トルの抽出溶媒を加えた溶液に上記試料を 1 k g浸漬し、 同様に常温で 1 日間静置した後ろ過して二次抽出液を得た。 この二次抽出液にさらに 1 リ ッ トルの抽出溶媒を加えた溶液に上記試料 を l k g浸漬し、 同様に常温で 1 日間静置した後ろ過して最終抽出液 1 および 2 (葉部および茎部) を得た。 上記のよ うにして得られた各最終抽出液をそれぞれ 8 0 °C程度に加温 して約 2時間加熱を行い、 アルコール分を蒸散させると ともに抽出液を 元の抽出溶媒の約 1 0分の 1 (約 3 0 0 c c ) になるまで濃縮を行って エキス試料 1 (葉部) およびエキス試料 2 (茎部) を得た。 1 kg of each of the above samples was immersed in 1 liter of the above extraction solvent, allowed to stand at room temperature for 1 day, and filtered to obtain a primary extract. 1 kg of the above sample is immersed in the solution obtained by adding 1 liter of extraction solvent to the primary extract thus obtained, and the mixture is allowed to stand at room temperature for 1 day and then filtered to obtain a secondary extract I got The sample solution extraction solvent followed by addition of further 1 liter in the secondary extract was lk g immersed, similarly final extract 1 and 2 was filtered after standing for 1 day at room temperature (leaves and I got the stem). Each final extract obtained as described above is heated to about 80 ° C. and heated for about 2 hours to evaporate the alcohol and to extract the extract at about 100 ° C. The extract was concentrated to a half (about 300 cc) to obtain extract sample 1 (leaf) and extract sample 2 (stem).
〔チロシナーゼ活性阻害作用〕  [Tyrosinase activity inhibitory action]
エキス試料 1 (葉部) およびエキス試料 2 (茎部) について、 メラ二 ンの生成に関与する酵素であるチロキシナーゼ活性の阻害作用を調べた。 チロシナーゼ (E C 1 . 1 4 . 1 8 . 1 ) は L一 t y r o s i n e を L— D O P Aに酸化すると共に L— D O P Aを D O P Aキノ ン に酸化させる生体酵素である。 D O P Aキノンはシミやそばかすの原因 物質であるメ ラニンの原因物質であることから、 チロシナーゼを阻害す ることで、シミやそばかすの生成を防ぐことが可能であると考えられる。  Extract sample 1 (leaf) and extract sample 2 (stem) were examined for their inhibitory effect on tyroxinase activity, an enzyme involved in the formation of melanin. Tyrosinase (EC1.14.18.1) is a bioenzyme that oxidizes L-tyroosine to L-DOPA and oxidizes L-DOPA to DOPA-quinone. Since DOPA quinone is a causative agent of melanine which is a causative agent of stains and freckles, it is considered that inhibiting tyrosinase can prevent the formation of stains and freckles.
2 0 %DM S O含有リ ン酸緩衝液 (p H 6 . 8 ) に溶解した試料 ( 2 0 μ L ) に 0. 1 M L— D O Ρ Αを含む基質 ( 1 0 0 ;z L ) に懸濁した 酵素液 (マッシュルーム由来チロシナーゼ 3 0 U, S I GMA社製, 2 0 μ L· ) をよく混合し、 3 7 °Cの恒温槽中で 1 5分間酵素反応させた。 その後、 反応停止液と して 0. 1 N H C L水溶液 ( 2 0 μ L ) を加えた ( S)。 同時に基質と試料の代わりにリ ン酸緩衝液を用いたもの (S · B 1 )、 試料の代わりにリ ン酸緩衝液を用いたもの (B 1 ) を調製した。 酵 素反応後、 リ ン酸緩衝液 ( p H 6 . 8 ) を測定ブランクと して、 4 7 5 n mにおける吸光度を測定し、 式 1 に従ってチロシナーゼ阻害率 (%) を算出した。 なお、 試料の濃度は 5 m g Zm L (水希釈) と した。  The sample (20 μL) dissolved in phosphate buffer (pH 6. 8) containing 20% DM SO was suspended on a substrate (100; z L) containing 0.1 ML-DO. The turbid enzyme solution (mushroom-derived tyrosinase 30 U, manufactured by SIGMA, 20 μL ·) was thoroughly mixed and subjected to enzyme reaction for 15 minutes in a thermostat bath at 37 ° C. After that, 0.1 N aqueous solution of HCl (20 μL) was added as a reaction stop solution (S). At the same time, one was prepared using a phosphate buffer instead of the substrate and the sample (S · B 1) and one using a phosphate buffer instead of the sample (B 1). After the enzyme reaction, the phosphate buffer (pH 6.8) was used as a measurement blank, and the absorbance at 45 nm was measured, and the tyrosinase inhibition rate (%) was calculated according to formula 1. The sample concentration was 5 mg zml (water dilution).
阻害率 (%) = B 1 — ( S - S · B 1 ) / B 1 X 1 0 0 - . ' (式 1 ) 〔 S O D様活性 ; 活性酸素除去効果〕 Inhibition rate (%) = B 1-(S-S · B 1) / B 1 X 1 0 0-. '(Equation 1) [S OD like activity; active oxygen scavenging effect]
先に述べたチロシナーゼは紫外線によって生じた活性酸素を引き金と して、 皮膚の基底層に存在するメラノサイ トと呼ばれる細胞内で生産さ れる。 つまり、 チロシナーゼの阻害に加えて、 チロシナーゼの活性上昇 を引き起こす活性酸素を効果的に抑制することができれば、 美白効果も 期待できると考えられる。 The previously mentioned tyrosinase is triggered by active oxygen generated by ultraviolet light and is produced in cells called melanosite present in the basal layer of the skin. Be That is, in addition to the inhibition of tyrosinase, if it is possible to effectively suppress the active oxygen causing the activity of tyrosinase, it is considered that a whitening effect can be expected.
活性酸素抑制効果は S O D A c t i v i t y D e t e c t i o n K i t (和光純薬社製) を用いて、 標準操作法に従って測定した。 すな わち、 2 0 %DM S O水溶液と した蒸留水に溶解させた試料溶液 1 0 μ Lに発色試薬(キサンチン 0. 4 μ Μとニ トロブルーテ トラゾリ ゥム 0. 2 4 μ Μ含有 0. 1 Μリ ン酸緩衝液 ( ρ Η 8. 0 )) 0. l m Lを加え、 1分間攪拌した。 続いて酵素懸濁液 (キサンチンォキシダーゼ (B u t t e r m i l k由来) 0. 0 4 9 U m Lを 0. 1 Mリ ン酸緩衝液 ( p H 8. 0 ) に懸濁したもの) 0. 1 m Lに加え 3 7 °Cの恒温槽中で 2 8 分間反応させた後、 速やかに反応停止液 ( 6 9 O mMドデシル硫酸ナ ト リ ウム, 2 0 L) を加えて 5分間攪拌した ( S )。 なお、 試料の濃度は 1 0 0 μ g /m L (水希釈) と した。  The reactive oxygen inhibition effect was measured according to a standard operation method using S O D A c t i t i d i d t e i t i t i o i K i t (manufactured by Wako Pure Chemical Industries, Ltd.). That is, a coloring reagent (containing 0.5 μm of xanthine and 0.42 μm of nitro bluet triazolium) in 10 μl of a sample solution dissolved in distilled water containing a 20% aqueous solution of DM SO. 1 phosphate buffer (ρ Η 8. 0)) 0. lm L was added and stirred for 1 minute. Subsequently, an enzyme suspension (a suspension of 0.10 4 9 U ml of Xanthine Oxidase (derived from Buttermilk) in 0.1 M phosphate buffer (pH 8. 0)) 0.1 m In addition to L, the mixture was allowed to react for 28 minutes in a 37 ° C constant temperature bath, and then the reaction stopping solution (69 O mM sodium dodecyl sulfate, 20 L) was added rapidly and stirred for 5 minutes (S ). The concentration of the sample was 100 μg / mL (water dilution).
同時に、 試料の代わりに同体積の蒸留水を用いたもの (B 1 )、 酵素液 の代わりにブランク液を用いたもの ( S · B 1 )、 および試料溶液の代わ りに同体積の蒸留水を用い、 さらに酵素液の代わりにブランク液を用い たもの (B 1 . B 1 ) を調製した。 このよ うにして調製した、 試験溶液 は蒸留水を測定ブランクと して 5 6 0 n mにおける吸光度から式 2に従 つて活性酸素阻害率 (%) を算出した。  At the same time, use the same volume of distilled water instead of the sample (B 1), use the blank solution instead of the enzyme solution (S · B 1), and use the same volume of distilled water instead of the sample solution. A solution (B1.B1) was prepared using a blank solution instead of the enzyme solution. The test solution thus prepared used distilled water as a measurement blank, and the active oxygen inhibition rate (%) was calculated according to the equation 2 from the absorbance at 5600 nm.
活性酸素阻害率 (%) = (B 1 - B 1 · B 1 ) — ( S - S · B 1 ) / ( B 1 - B 1 · B 1 ) X 1 0 0 · · · (式 2 ) Reactive oxygen inhibition rate (%) = (B 1-B 1 · B 1)-(S-S · B 1) / (B 1-B 1 · B 1) X 1 0 0 · · · · (Equation 2)
〔ヒアル口ニダーゼ阻害率〕  [Heal mouth nidase inhibition rate]
牛睾丸由来のヒアル口 -ダーゼを用いて、 c o m p o u n d 4 8 / 8 0による、 不活性型酵素の活性化段階の阻害作用を中心に測定した。 酵 素活性は、 ヒアルロン酸の加水分解により生成する N—ァセチルへキソ サミンを還元末端とする四糖の還元力の増加を 5 8 5 n mにおける吸光 度で比色定量することにより測定した (食衛誌、 3 1卷、 2 3 3〜 2 3 7頁、 1 9 9 0 )。 Using the hyaluronic acid-derived calf testis, the inhibitory effect on the activation step of the inactive enzyme by compound 48/80 was mainly measured. The enzyme activity is N-acetyl hexoside produced by hydrolysis of hyaluronic acid. The increase in reducing power of tetrasaccharides having a reducing end with samin was measured by colorimetric determination with absorbance at 585 nm (Goery Journal, 31: 23-3237, 19) 9 0).
まず、 試薬と して以下のものを準備した。  First, the following were prepared as reagents.
· 0. 1 M 酢酸緩衝液 (p H 4. 0)  · 0.1 M acetate buffer (pH 4.0)
■ · ヒアノレロニダーゼ ■ · Hyanoleronidase
• c o m p o u n d 4 8 //8 0 • compound 4 8 / / 8 0
' ヒアルロ ン酸ナト リ ウム溶液  'Sodium hyaluronate solution
• 0. 4 N水酸化ナ ト リ ゥム溶液  • 0.4 N sodium hydroxide solution
· p— D A B試薬 : p— D A B 1 0 g、 1 0 N塩酸溶液 1 2. 5 m 1 、 酢酸 8 7. 5 m 1 を混合し、 使用直前に酢酸で 1 0倍希釈した。  · P-DA reagent: 10 g of p-DAB, 2.5 m 1 of 10 N hydrochloric acid solution, and 8 7.5 m 1 of acetic acid were mixed and diluted 10-fold with acetic acid immediately before use.
• ホウ酸溶液 : ホウ酸 4. 9 5 gに水 5 0 m 1 を加え、 1 N水酸化ナト リ ウム溶液で pH9. 1に調整した後、 水を加えて 1 0 0 m 1 と した。 そして、 ヒアルロニダーゼ阻害率を下記の方法で測定した。  • Boric acid solution: 50m1 of water was added to 4.95g of boric acid, adjusted to pH 9.1 with a 1 N sodium hydroxide solution, and then water was added to make it 100m1. And, the hyaluronidase inhibition rate was measured by the following method.
1 ) 5 m g 1 に水で希釈したサンプル溶液 2 0 0 μ 1 と ヒアルロニ ダーゼ 1 0 0 /i l ( 4 0 0 u n i t s ) を混合して 3 7 °Cで 2 0分間培 養した。  1) The sample solution 200 μl diluted with water was mixed with 5 mg 1 and hyaluronidase 100 / il (40 0 n i t s) mixed and cultured at 37 ° C. for 20 minutes.
2) c o m p o u n d S Z S Oを 2 0 0 μ 1 (最終濃度 0. 1 m g / m l ) 添加して 3 7 °Cで 2 0分間培養した。  2) 200 μl (final concentration 0.1 mg / ml) of comonomer was added and the mixture was incubated at 37 ° C for 20 minutes.
3 ) ヒアルロ ン酸ナ ト リ ウム溶液 5 0 0 μ 1 (最終濃度 0. 4 m gZm 1 ) を加えて 3 7 °Cで 4 0分間培養した。  3) An aqueous solution of sodium hyaluronate 500.mu. 1 (final concentration: 0.4 mg Zm.sup.1) was added and the mixture was incubated at 37.degree. C. for 40 minutes.
4) 0. 4 N水酸化ナ ト リ ウム溶液 2 0 0 μ 1 を加えて氷上へ置き、 ,反 応を停止した。  4) 0.20 μl of 0.4 N sodium hydroxide solution was added and placed on ice to stop the reaction.
5 ) ホウ酸溶液 2 0 0 μ 1 を加えて 1 0 0 °Cで 3分間処理した。  5) 200 μl of boric acid solution was added and treated for 3 minutes at 100 ° C.
6 ) 反応溶液 1 4 0 1 と p— DAB溶液 6 0 0 AZ 1 を混合して 3 7 °C で 2 0分間培養した。 7 ) 5 8 5 n mにおける吸光度を測定した。 6) Reaction solution 1401 and p-DAB solution 600 AZ 1 were mixed and incubated at 37 ° C. for 20 minutes. 7) Absorbance at 585 nm was measured.
下記の表 1に従って調製した S a m p 1 e、 C o n t r o 1 、 S— B l a n k , C— B l a n kの測定試料を調製してそれぞれの吸光度を測 定し、下記の式 3からヒアルロニダーゼ阻害率(阻害活性) を算出した。 なお、 X印は、 左欄の溶液に代えて上記酢酸緩衝液を用いて調製したこ とを示す。  The measurement samples of S amp 1 e, C ontro 1, S-B lank and C-B lank prepared according to Table 1 below are prepared and their respective absorbances are measured, and the hyaluronidase inhibition rate (inhibition from Activity) was calculated. The X mark indicates that the above-mentioned acetate buffer was used instead of the solution in the left column.
ヒアル口ニダーゼ阻害率 (%) = ( C - C - B L ) 一 ( S - S - B L ) / (S - S - B L) X I O O - · ' (式 3)  Hyalid nidase inhibition rate (%) = (C-C-B L)-(S-S-B L) / (S-S-B L) X I O O-· '(Equation 3)
S : S a m p 1 eの吸光度 S: Absorbance of S a m p 1 e
C : C o n t r o 1 の吸光度 C: Absorbance of C o n t r o 1
S * B L : S _ B l a n kの吸光度 S * B L: Absorbance of S _ B l a n k
C - B L : C - B l a n kの吸光度 表 1 C-B L: Absorbance of C-B l a n k Table 1
Figure imgf000014_0001
上記のようにして測定したチロシナーゼ阻害率、 S OD様活性、 ヒア ルロニダーゼ阻害率の測定結果を下記の表 2に示す。 比較例と して、 二 ガウリの葉部を同様に抽出したエキスについての測定結果を併せて示す。 表 2 試料 チロシナーゼ阻害率 (%) SOD様活性 (¾) ヒアルロニダ一ゼ阻害率 (%) イチゴ葉部 81.1 99.5 97.0
Figure imgf000014_0001
The measurement results of the tyrosinase inhibition rate, the S OD-like activity, and the hyaluronidase inhibition rate measured as described above are shown in Table 2 below. As a comparative example, measurement results of extracts obtained by similarly extracting the leaves of Niugori are also shown. Table 2 Sample Tyrosinase inhibition rate (%) SOD-like activity (3⁄4) Hyaluronidase inhibition rate (%) Strawberry leaf 81.1 99.5 97.0
イチゴ茎部 75.3 100.0 94.6  Strawberry stem 75.3 100.0 94.6
二ガウリ葉部 22.5 28.5 Not Inhibit 上記表 2からわかるとおり、 実施例 (エキス試料 1および 2 ) は、 チ ロシナーゼ阻害率、 S O D様活性、 ヒアルロニダーゼ阻害率ともに極め て高い良好な値をとる。 一方、 比較例は、 ヒアルロニダーゼ阻害率につ いてはほとんど阻害せず、 チロシナーゼ阻害率、 S O D様活性について は大幅に低い値をとつている。  As shown in Table 2 above, Examples (Extract samples 1 and 2) have extremely high values of tyrosinase inhibition rate, SOD-like activity, and hyaluronidase inhibition rate. On the other hand, the comparative example hardly inhibits the hyaluronidase inhibition rate, and has a significantly low value for the tyrosinase inhibition rate and the SOD-like activity.
また、 高いヒアルロニダーゼ阻害活性を示し、 優れた抗アレルギー作 用を有することから、 ァレルギ一性の皮膚炎等の治療や緩和効果も期待 できる。  In addition, since it exhibits high hyaluronidase inhibitory activity and has excellent antiallergic activity, it can also be expected to have a therapeutic or alleviating effect on dermatitis etc. of allergies.
〔化粧料と しての効果〕  [Effect as cosmetics]
エキス試料 1 (葉部) を 2 0 0 c c準備し、 4 0 0 c cのグリセ リ ン に混合希釈して化粧料を調製した。  Extract sample 1 (leaf) was prepared at 200 c c and mixed and diluted in 400 c c glycerol to prepare a cosmetic.
この化粧料を、 8人のパネラーに、 夜の洗顔後につける化粧料の代わ り と して 1 ヶ月間使用してもらつたところ、 以下のよ うな結果を得た。 パネラー 1 ( 5 1歳の女性):朝、起き洗顔するときのハリが感じられ、 ツルツル感がとてもここちよい。 その為か化粧する手間が楽になり、 化 粧崩れがしにく くなった。 休みに何のケアをしなくても一日中スッピン でおれる。  The following results were obtained when this cosmetic was used for eight months as a substitute for a cosmetic applied after face-washing at night for one month. Paneler 1 (5 1 year old woman): I feel firmness when I wake up and wash my face in the morning, I feel very smooth. As a result, the effort to put on makeup has become easier, and it has become difficult to lose makeup. You can stay there all day without taking care of your vacation.
パネラー 2 ( 6 5歳の女性) : 1 0円硬化ぐらいのシミが割れてきた。 しかも保湿性が非常に高く肌がきめ細かく なり、 ファンデーショ ンの伸 びが今までと倍以上の違いがある。  Paneler 2 (woman of 65 years old): The stain of about 10 yen hardening has broken. In addition, it has very high moisturizing properties and fine-grained skin, and there is more than double the extension of the foundation.
パネラー 3 ( 6 4歳の女性) :年齢による全体的なシミが薄くなり、 肌 が白く なつてきたといわれるようになった。 今までに経験がないぐらい の保湿性です。 Paneler 3 (a woman of 64 years old): The overall age spots became pale, and it was said that the skin became white. I have no experience so far It is moisturizing.
パネラー 4 ( 4 0歳の女性) :乾燥肌ですが、 サンプル品を使用しだし てから、 何もケアしなくてもしっと り感が保てるよ うになった。 また、 ァレルギ一体質による吹き出物が少なくなってきた。  Paneler 4 (40-year-old woman): Although it is dry skin, after using the sample products, it became possible to feel a sense of security without taking any care. In addition, the number of blowouts due to the quality of allergies has decreased.
パネラー 5 ( 3 6歳の女性):毛穴が大きくなり化粧ノ リが悪いのが 1 回の使用で改善が感じられた。 しかも、 目の周りの黒ずみもとれてきだ した。  Paneler 5 (36-year-old woman): It was felt that the pores became large and cosmetic makeup was bad after one use. Moreover, I was getting darker around my eyes.
パネラー 6 ( 3 4歳の女性) : 1回使用しだだけで、 化粧ノ リ の違いが はっき り とわかった。顔全体のクスミのようなものが消えてきた。また、 保湿性がよく洗顔した後に、 なにもしなくていつまでもしっと り してい る。  Paneler 6 (34-year-old woman): I found that the difference in cosmetic makeup was clear when used only once. Things like Kusumi in the whole face have disappeared. In addition, after being well moisturized, I have not been doing anything until now.
パネラー 7 ( 5 1歳の男性):幾つかあるソバカスが薄くなり縮小して きた。 1 0 日程度で気がついた。  Paneler 7 (Male, 51 years old): Some buckwheat have become thinner and smaller. I noticed in about 10 days.
パネラー 8 ( 6 5歳の男性) :肌が脂性で気になっていたが、 サンプル を使用するようになり脂性が改善され、何も気にならなくなった。また、 残ったサンプルを左手にだけ使甩したところ白くなり、 右手と色の違い がはっき り とわかり驚いている。  Paneler 8 (65-year-old man): The skin was oily and bothersome, but the sample became used and the oiliness was improved and nothing bothered. In addition, when the remaining sample is used only in the left hand, it becomes white, and I am surprised that the difference between the right hand and the color is clearly seen.
パネラー 1〜 8の結果からわかるように、 本発明の化粧料は、 保湿性 が非常に高く、 シミゃソバカス等の脱色、 低減、 消去に効果がある。 ま た、 参加者の大半の感想と して" 肌がふつく らして若返ったようだ" と いう声が多く あった。 また、 痒みや刺激性等の副作用といわれるような 事は全くなかった。  As can be seen from the results of panelists 1 to 8, the cosmetic composition of the present invention is very moisturizing, and is effective in decolorization, reduction, and elimination of Shiva, etc. Also, many of the participants commented that most of the participants said, "The skin seems to have revived." Also, there was no such thing as side effects such as itching or irritation.
〔分画試料のチロシナーゼ阻害活性評価〕  [Evaluation of tyrosinase inhibitory activity of fractionated sample]
く試料の調整〉 Sample preparation>
オランダイチゴの葉部を自然乾燥させた後手指で揉んで数 m m〜数 c m程度に砕いた試料 ( 8 7 . 6 g ) を 5 0 %エタノール水溶液 ( 1 . 8 1 ) に浸漬して 3 日間常温で抽出した。 得られた抽出液をろ過後、 再度 同量の 5 0 %ェタノール水溶液を加えた溶液に上記試料を加えて 3 日間 常温で抽出を行なった。 ろ過後の抽出液を合わせて容積が 5 0 c cにな るまで減圧濃縮して、 オランダイチゴ葉 5 0 %エタノール抽出物サンプ ル溶液を得た。 After drying the leaves of the Dutch strawberry naturally, the sample (87. 6 g) crushed by hand with a finger and crushed to several mm to several cm is mixed with 50% aqueous ethanol solution (1.8 1) Immersed in 1) and extracted at room temperature for 3 days. After the obtained extract was filtered, the above sample was added to a solution to which the same amount of 50% aqueous ethanol solution was added again, and extraction was performed for 3 days at normal temperature. The extracts after filtration were combined and concentrated under reduced pressure until the volume became 50 cc to obtain a solution solution of 50% ethanol extract of Dutch strawberry leaves.
<チロシナーゼ阻害活性試験 >  <Tyrosinase inhibitory activity test>
2 0 %DM S O含有リ ン酸緩衝液 ( p H 6. 8 ) に溶解した試料 ( 2 Ο μ ΐ ) に 0. 1 ML— DO P Aを含む基質 ( Ι Ο Ο μ Ι ) に懸濁した 酵素液 (マッシュルーム由来チロシナーゼ 3 0 U, S I GMA社製, 2 Ο μ ΐ ) をよく混合し、 3 7°Cの恒温槽中で 1 5分間酵素反応させた。 その後、 反応停止液と して 0. 1 NHC L水溶液 ( 2 0 μ 1 ) を加えた (S)。 同時に基質と試料の代わりにリ ン酸緩衝液を用いたもの ( S · B 1 )、 試料の代わりにリ ン酸緩衝液を用いたもの (B 1 ) を調整した。 酵 素反応後、 リ ン酸緩衝液 (p H 6. 8 ) を測定ブランクと して、 4 7 5 nmにおける吸光度を測定し、 下記の式 4に従ってチロシナ一ゼ阻害率 (%) を算出した。 なお、 試料の濃度は 5 m g /m L (水希釈) と した。 チロシナーゼ阻害率 (%) = B 1 ― ( S— S · Β 1 ) /Β 1 X I 0 0 · · · (式 4 )  The sample (20 μM) dissolved in phosphate buffer (pH 6. 8) containing 20% DM 2 SO was suspended in a substrate containing 0.1 μM-DOPA (μM buffer) The enzyme solution (mushroom-derived tyrosinase 30 U, manufactured by SIGMA, 2 μM) was mixed well and subjected to enzyme reaction in a thermostat at 37 ° C. for 15 minutes. After that, 0.1 NHCL aqueous solution (20 μl) was added as a reaction stop solution (S). At the same time, those using phosphate buffer instead of substrate and sample (S · B 1) and those using phosphate buffer instead of sample (B 1) were prepared. After the enzyme reaction, absorbance was measured at 45 nm using phosphate buffer (pH 6. 8) as a measurement blank, and tyrosinase inhibition rate (%) was calculated according to the following equation 4. . The sample concentration was 5 mg / mL (water dilution). Tyrosinase inhibition rate (%) = B 1-(S-S · Β 1) / Β 1 X I 0 0 · · · · (Equation 4)
上述した抽出物サンプル溶液では、 8 1. 1 %のチロシナーゼ阻害活 性が認められた。 また、 上記抽出物 (約 2 0. 4 g ) を水と酢酸ェチル にて液液分配して水画分 (約 1 1. 4 g ) と酢酸ェチル画分 (約 2. 6 g ) を得た。 水画分に 7 9. 5 %のチロシナーゼ阻害活性が認められ、 酢酸ェチル画分の 4 7. 8 %より も高い値.を示した。  The above-described extract sample solution showed 81. 1% tyrosinase inhibitory activity. Also, the above extract (about 20. 4 g) is liquid-liquid partitioned between water and ethyl acetate to obtain a water fraction (about 11. 4 g) and an ethyl acetate fraction (about 2.6 g). The The water fraction showed 79.5% tyrosinase inhibitory activity, which was higher than 47.8% of the ethyl acetate fraction.
そこで、 上記水画分を D I ANON H P— 2 0カラムクロマ トグラ フィ一にて分画し、 水画分 (約 3. 9 g )、 2 5 %メタノール水溶液溶出 画分 (約 1. 9 g )、 5 0 %メ タノール水溶液溶出画分 (約 1. 3 g )、 7 5 %メタノール水溶液溶出画分 (約 1 3 4. 0 m g )、 メタノ一ル溶出 画分 (約 3 3. 9 m g ) を得た。 それぞれのチロシナーゼ阻害活性は、 水画分が 2 0. 1 %、 2 5 %メタノール水溶液溶出画分が 8 7. 8 %、Therefore, the above water fraction was fractionated with DI ANON HP-20 column chromatography, and the water fraction (about 3.9 g), the fraction eluted with 25% methanol aqueous solution (about 1. 9 g), 50% methanol aqueous solution elution fraction (about 1.3 g), The fraction eluted with 75% aqueous methanol solution (about 134.0 mg) and the fraction eluted with methanol (about 33.9 mg) were obtained. The respective tyrosinase inhibitory activity was 20. 1% in water fraction, 87.8% in 25% methanol aqueous solution eluted fraction,
5 0 %メタノール水溶液溶出画分が 7 5. 5 %、 7 5 %メタノール水溶 液溶出画分が 5 5. 1 %、 メタノール溶出画分が 1 8. 2 %であり、 2The fraction eluted with 50% methanol aqueous solution is 75.5%, the fraction eluted with 75% methanol aqueous solution is 55.1%, and the fraction eluted with methanol is 18.2%,
5 %メタノール水溶液溶出画分に高いチロシナーゼ阻害活性が認められ た。 A high tyrosinase inhibitory activity was observed in the 5% methanol aqueous solution eluted fraction.
つぎに、 2 5 %メタノール水溶液溶出画分 (約 8 6 6. 9 m g ) につ いて、 HP L C (液体クロマ トグラフィー) にて成分の分画精製を行な つた。 すなわち、 あらかじめ同じ試料について実施した H P L Cのクロ マ トパターンに従い、主要成分が溶出する時間を基準と して F r . 1 (約 5 2 5.8 m g )、 F r . 2 (約 4 4.8 m g )、 F r . 3 (約 1 1.9 m g )、 F r . 4 (約 3 4.8 m g )、 F r . 5 (約 4 8.3 m g ) の 5画分に分画 した。 なお、 H P L Cの分析条件は以下のとおりである。  Next, with respect to the fraction eluted with 25% methanol aqueous solution (about 869. 9 mg), the components were fractionated and purified with HP LC (liquid chromatography). That is, according to the HPLC chromatography pattern previously performed for the same sample, F r. 1 (about 52 5.8 mg), F r. 2 (about 4 4.8 mg), based on the elution time of the main component. Fractions of F r. 3 (about 1 1.9 mg), F r. 4 (about 3 4.8 mg) and F r. 5 (about 4 8.3 mg) were made. The analysis conditions of H P L C are as follows.
機種 : S I MA Z U S C L - 1 0 AV P  Model: S I MA Z U S C L-1 0 AV P
カラム : U n i s o n UK— C 1 8 ( I m t a k t )  Column: U n i so n UK — C 18 (I m t a k t)
溶出溶剤 : 1 8 %ァセ トニ ト リル  Dissolution solvent: 18% acetonitrile
流速 : l ml^/ m i n  Flow rate: l ml ^ / min
検出器 : UV検出器 2 5 4 n m、 3 3 0 n m  Detector: UV detector 2 5 4 n m, 3 3 0 n m
それぞれのチロシナーゼ阻害活性は、 F r . 1が 2 7. 0 %、 F r . 2が不活性、 F r , 3力 S 9 6. 4 %、 F r . 4が不活性、 F r . 5力 S 2 7. 9 %であり、 F r . 3に高いチロシナーゼ阻害活性が認められた。 これらの結果を図 1に示す。  Each tyrosinase inhibitory activity was 27.0% for F r. 1 and inactive for F r. 2, F r, 3 force S 9 6.4%, F r. 4 for inactive, F r. 5 The strength was S 2 7. 9%, and F r. 3 showed high tyrosinase inhibitory activity. These results are shown in FIG.
〔分画試料の S O D様活性評価〕  [SOD-like activity evaluation of fractionated sample]
く S OD様活性試験 > S S OD like activity test>
活性酸素抑制効果は S OD A c t i v i t y D e t e c t i o n K i t (和光純薬社製) を用いて、 標準操作法に従って測定した。 すな わち、 2 0 %DM S O水溶液と した蒸留水に溶解させた試料溶液 1 0 μ Lに発色試薬(キサンチン 0. 4 ju Mとニ トロブルーテ トラゾリ ゥム 0. 2 4 μ Μ含有 0. 1 Mリ ン酸緩衝液 ( ρ Η 8. 0)) 0. l m Lを加え、 1分間攪拌した。 続いて酵素懸濁液 (キサンチンォキシダーゼ (B u t t e r m i l k由来) 0. O S UZmLを 0. I M ン酸緩衝液 ( p H 8. 0) に懸濁したもの) 0. 1 m Lに加え 3 7 °Cの恒温槽中で 2 8 分間反応させた後、 速やかに反応停止液 ( 6 9 0 mMドデシル硫酸ナト リ ウム, を加えて 5分間攪拌した ( S )。 なお、 試料の濃度は 1 0 0 μ g /m L (水希釈) と した。 Reactive oxygen suppression effect is S OD A ctivity D etection It measured according to the standard procedure using Kit (made by Wako Pure Chemical Industries, Ltd.). That is, the color reagent (Xanthine 0.4 M and NitroBluete trazolium 0.24 μm contained) in 10 μL of the sample solution dissolved in distilled water containing 20% aqueous DM 2 SO 4. 1 M phosphate buffer (ρ Η 8. 0)) 0. lm L was added and stirred for 1 minute. Enzyme suspension (Xanthine oxidase (derived from Buttermilk) 0. OS UZmL suspended in 0. IM acid buffer (pH 800) 0. 1 ml added to 0. 7 ml 37 ° The reaction was allowed to proceed for 28 minutes in a thermostatic bath C. Then, a reaction termination solution (690 mM sodium dodecyl sulfate) was rapidly added, and the mixture was stirred for 5 minutes (S). The concentration was μg / mL (water dilution).
同時に、 試料の代わりに同体積の蒸留水を用いたもの (B 1 )、 酵素液 の代わりにブランク液を用いたもの ( S · B 1 )、 および試料溶液の代わ りに同体積の蒸留水を用い、 さらに酵素液の代わりにブランク液を用い たもの (B 1 · B 1 ) を調製した。 このようにして調製した、 試験溶液 は蒸留水を測定ブランク と して 5 6 0 n mにおける吸光度から下記の式 5に従って活性酸素阻害率 (%) を算出した。  At the same time, use the same volume of distilled water instead of the sample (B 1), use the blank solution instead of the enzyme solution (S · B 1), and use the same volume of distilled water instead of the sample solution. In addition, using the blank solution instead of the enzyme solution (B 1 · B 1) was prepared. The test solution thus prepared used distilled water as a measurement blank, and the active oxygen inhibition rate (%) was calculated according to the following equation 5 from the absorbance at 5600 nm.
活性酸素阻害率 (%) = (B 1 — B 1 · B 1 ) - (S - S · B 1 ) / (B 1 - B 1 · B 1 ) X 1 0 0 · · · (式 5 ) Reactive oxygen inhibition rate (%) = (B 1-B 1 · B 1)-(S-S · B 1) / (B 1-B 1 · B 1) X 1 0 0 · · · · (Equation 5)
上記 F r . 2および F r . 4について S O D様活性を測定すると、 F r . 2力 S 9 0. 8 %、 F r . 4力; 9 1. 4 %の高い値を示した。  Measurement of the SOD-like activity for the above F r. 2 and F r. 4 showed high values of F r. 2 force S 9. 0 8%, F r. 4 force; 9 1. 4%.
〔構造解析〕 [Structural analysis]
つぎに、 上記 F r . 2、 F r . 3および F r . 4をそれぞれ C o m p o u n d 1、 C o m p o u n d 2および C o m p o u n d 3 と し、 質量分析法 (F AB— MS)、 核磁気共鳴分光法 (NMR) 等によ り構造 解析を行なった。 く C o m p o u n d 3 > Next, the above-mentioned F r. 2, F r. 3 and F r. 4 are respectively C ompound 1, C ompound 2 and C ompound 3, mass spectrometry (F AB-MS), nuclear magnetic resonance spectroscopy ( Structural analysis was performed by NMR) and the like. C ompound 3>
まず、 C o m p o u n d 3についての質量分析法 (FAB— MS)、 核磁気共鳴分光法 (NMR) の測定結果を以下に示す。 また、 C o m p o u n d 3の1 H— NMRスペク トルを図 2に示す。 First, the measurement results of mass spectrometry (FAB-MS) and nuclear magnetic resonance spectroscopy (NMR) for C ompound 3 are shown below. Also, 1 H-NMR spectrum of C ompound 3 is shown in FIG.
( 1 ) F AB -MS : m/ z = 4 7 9 [M+H] + (1) F AB-MS: m / z = 4 7 9 [M + H] +
( 2 ) 1 H - NMR ( C D a O D) δ ( p p m) (2) 1 H-NMR (CD a OD) δ (ppm)
3. 4 3— 3. 7 7 ( 4 H, m, C 2 ", C 3 ", C 4 ", C 5,,)、 5. 3 3. 4 3-3. 7 7 (4 H, m, C 2 ", C 3", C 4 ", C 5,,), 5. 3
3 (1H, d , J = 7. 4 H z , C Iつ、 6. 1 9 ( 1 H, d , J = 1. 8 H z , C 6)、 6. 3 8 ( 1 H, d, J = 1. 8 H z , C 8)、 6. 83 (1H, d, J = 7.4 Hz, CI, 6. 1 9 (1 H, d, J = 1. 8 H z, C 6), 6. 38 (1 H, d, J = 1. 8 H z, C 8), 6. 8
4 ( 1 H, d, J = 9. 0 H z, C 5 ')、 7. 6 2 ( 2 H, C 2 C 6,) ( 3 ) 1 3 C - NMR (C D 3 O D) δ ( p p m) 4 (1 H, d, J = 9.0 H z, C 5 '), 7. 6 2 (2 H, C 2 C 6, 6) (3) 1 3 C NMR (CD 3 OD) δ (ppm) )
7 3. 6 (C 4 ")、 7 6. 2 (C 2")、 7 7. 8 (C 5 ")、 7 8. 4 (C 3,,)、 9 5. 5 (C 8 )、 1 0 0. 7 (C 6 )、 1 0 5. 0 (C l,,)、 1 0 6. 4 (C 1 0)、 1 1 6. 8 (C 5,)、 1 1 8. 0 (C 2 ')、 1 2 3. 6 (C l ,)、 1 2 4. 3 (C 6 ')、 1 3 6. 2 (C 3)、 1 4 6. 7 ( C 3 ')、 1 5 0. 7 (C 4,)、 1 5 9. 2 (C 9 )、 1 5 9. 8 (C 2 )、 1 6 3. 8 (C 5 )、 1 6 6. 8 (C 7 )、 1 7 3. 1 (C 6 ")、 1 8 0. 0 (C 4 )  7 3.6 (C 4 "), 7 6.2 (C 2"), 7 7. 8 (C 5 "), 7 8.4 (C 3,,), 9 5.5 (C 8), 1 0 0. 7 (C 6), 1 0 5. 0 (C 1 ,,), 1 0 6. 4 (C 1 0), 1 1 6. 8 (C 5,), 1 1 8. 0 C 2 '), 1 2 3. 6 (C 1,), 1 2 4.3 (C 6'), 1 3 6. 2 (C 3), 1 4 6. 7 (C 3 '), 1 5 0.7 (C 4,), 1 59.2 (C 9), 1 59.8 (C 2), 1 6 3.8 (C 5), 1 6 6. 8 (C 7), 1 7 3.1 (C 6 "), 1 8 0. 0 (C 4)
以上の分析の結果および文献値より、 C o m p o u n d 3を q u e r c e t i n— 3— o— D— g 1 u c u r o n i d e と同定した。 その 構造を図 3に示す。  From the results of the above analysis and the literature values, C o m p o u n d 3 was identified as q u e r c e t i n-3-o-D-g 1 u c u r o n i d e. The structure is shown in Fig.3.
参考文献: K. R. P r i c e , I . J . C o 1 q u h o u n, K . A . B a r n e s , M. J . C . R h o d e s , J . A g r i c . F o o d C h e m. 4 6. 4 8 9 8— 4 9 0 3 ( 1 9 9 8 ) < C o m p o u n d 1 > References: KR Price, I. J. Co. 1 quhoun, K. A. Barnes, M. J. C. Rhodes, J. A. gric .. Food C. Hem. 4 6. 4 8 9 8 — 4 9 0 3 (1 9 9 8) <C ompound 1>
ついで、 C o m p o u n d 1についての核磁気共鳴分光法 (NMR) の測定結果を以下に示す。 また、 C o m p o u n d 1の 1 H— NMR スぺク トノレを図 4に示す。 Next, the measurement results of nuclear magnetic resonance spectroscopy (NMR) for C ompound 1 are shown below. Also, 1 H—NMR spectrum of C ompound 1 is shown in FIG.
( 1 ) 1 H - NMR (CD 3OD) δ ( p p m) (1) 1 H-NMR (CD 3 OD) δ (ppm)
3. 1 7 - 3. 9 4 (m, s u g a r )、 4. 7 5 , 5. 5 9 ( 2 H, an o m e r i c p r o t o n)、 6. 1 7 ( 1 H , b r s )、 6. 3 6 ( 1 H, b r s ), 6. 8 6 ( 1 H, d , J = 8. 0 H z ) , 7. 6 2 ( 2 H)  3. 1 7-3. 9 4 (m, sugar), 4. 7 5, 5. 5 9 (2 H, an omericproton), 6. 1 7 (1 H, brs), 6. 3 6 (1 H) , brs), 6. 8 6 (1 H, d, J = 8.0 H z), 7. 6 2 (2 H)
( 2) 1 3 C - NMR (C D 3OD) δ (p p m) (2) 13 C-NMR (CD 3 OD) δ (ppm)
6 7. 3、 7 1. 7、 7 3. 4、 7 5. 5、 7 7. 7、 7 8. 4、 8 2. 4、 9 5. 4、 1 0 0. 6 , 1 0 1. 7、 1 0 6. 0、 1 0 6. 5、 1 1 6. 8、 1 1 8. 0、 1 2 3. 8、 1 2 4. 3、 1 3 5. 6、 1 4 6. 8、 1 5 0. 5、 1 5 9. 1、 1 5 9. 2、 1 6 3. 8、 1 6 6. 5、 1 7 2. 9、 1 8 0. 0  6 7. 3, 7 1. 7, 7 3. 4, 5 5. 5, 7 7. 7, 7 8.4, 8 2.4, 9 5. 4, 1006, 10 1. 7, 1 0 6. 0, 1 0 6. 5, 1 1 6. 8, 1 1 8. 0, 1 2 3. 8, 1 2 4. 3, 1 3 5. 6, 1 4 6. 8, 1 5 0. 5, 1 5 9. 1, 1 5 9. 2, 1 6 3. 8, 1 6 6. 5, 1 7 2. 9, 1 8 0. 0
C o m p o u n d 1の1 H— NMRは C o m p o u n d 3に非常 に類似しており、 — NMRの 6. 2〜 7. 6 p p mにフラボノイ ド の特徴的なピークが検出された。 このうち、 7. 6 p p m、 6. 8 p p mのピークにより三置換ベンゼンと、 6. 2 p p m、 6. 4 p p mの二 本のダブレッ トより芳香環のメタ位カップリングが推測できる。 また、 3〜 6 p p m付近には糖由来のピークが存在し、 このうち糖ァノマー位 由来の水素と考えられるピークが 4 · 7 p p m、 5. 6 p p mに二本認 められることから、 二糖が存在すると考えられる。 1 H-NMR of C ompound 1 is very similar to C ompound 3, and characteristic flavonoid peaks were detected at 6.2 to 7. 6 ppm of NMR. Of these, the meta position coupling of the aromatic ring can be inferred from the tri-substituted benzene and the doublets of 6.2 ppm and 6.4 ppm from the peaks at 7.6 ppm and 6.8 ppm. In addition, since there is a sugar-derived peak in the vicinity of 3 to 6 ppm, of which a peak thought to be hydrogen derived from a sugar anomer position is recognized as a double peak at 4.7 ppm and 5. 6 ppm. Is considered to exist.
次に、 C o m p o u n d 1の1 3 C— NMRを C o m p o u n d 3 の1 3 C— NMRと比較すると、 6 7. 3 p p m、 7 1. 7 p p m, 8 2. 4 p p m、 1 0 1. 7 p p m以外のピーク力 Sほぼ、 C o m p o u n d 3 と一致した。 Next, when the 1 3 C-NMR of C ompound 1 compared with 1 3 C-NMR of C ompound 3, 6 7. 3 ppm , 7 1. 7 ppm, 8 2. 4 ppm, 1 0 1. 7 ppm Other than peak power S almost C ompound 3 Matched with.
以上の結果より、 C o m p o u n d 1は、 C o m p o u n d 3 ( q u e r c e t i n— 3— o _D— g 1 u c u r o n i d e ) に灰素を 4 つ持つ糖を加えた化合物であると推測できる。 C o m p o u n d 1の 推定構造を図 5に示す。 C o m p o u n d 2ク  From the above results, it can be inferred that C o m p o u n d 1 is a compound obtained by adding a sugar having 4 ash to C o m o p o u n d 3 (q u e r c e t i n-3-o _ D-g 1 u c u r o n i d e). The estimated structure of Com po u n d 1 is shown in Fig.5. C o m p o u n d 2
ついで、 C o m p o u n d 2についての核磁気共鳴分光法(NMR) および質量分析法 (F AB— MS) の測定結果を以下に示す。 また、 C o m p o u n d 2の1 H— NMRスぺク トノレを図 6に、 1 3 C— NMR スぺク ト/レを図 7に示す。 Next, the measurement results of nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (FAB-MS) for C ompound 2 are shown below. Also, 1 H NMR spectrum of C ompound 2 is shown in FIG. 6, and 13 C NMR spectrum / re is shown in FIG.
( 1 ) XH -NMR (C D 3 O D) δ ( p p m) (1) X H-NMR (CD 3 OD) δ (ppm)
3 3 9 ( d d , J = 4. 2 , 9. 1 H z ) , 3. 8 1 ( d , J = = 1 2. 3 3 9 (d d, J = 4.2, 9.1 H z), 3. 8 1 (d, J = = 1 2.
9 ) 、 4. 5 9 ( d d, J = 5. 5 , 1 0. 2 H z ) , 5 . 0 4 5. 5 ( m ) , 6 . 3 4 ( d , J = 1 5. 0 H z ) , 6. 3 5 ( d , J = 0. 89), 4.59 (dd, J = 5.5, 10.2 Hz), 5.04. 5 (m), 6.33 4 (d, J = 15.0 Hz) , 6. 3 5 (d, J = 0.8)
H z ) 、 6 • 4 2 ( s ) 、 6. 4 8 ( d , J = 3. 8 H z ) 、 6. 5 2 ( d ,Hz), 6 • 4 2 (s), 6.48 (d, J = 3.8 Hz), 6. 52 (d,
J = 1 5. 0 H z ) , 6. 5 9 ( d , J = 3. 8 H z ), 6. 6 9 ( s ) 、J = 15.0 Hz), 6. 5 9 (d, J = 3.8 Hz), 6. 6 9 (s),
6 8 1 ( d , J = 2. 0 H z ) , 7. 2 4 ( s ) 、 7. 3 8 ( d , J =6 8 1 (d, J = 2.0 Hz), 7. 2 4 (s), 7. 38 (d, J =
2. 0 H z ) 2.0 H z)
( 2) 1 3 C - NMR ( C D a O D ) δ ( p p m) (2) 13 C-NMR (CD a OD) δ (ppm)
6 4 5 、 6 9. 8、 . 7 0. 4、 7 2. 2、 7 2. 4 、 7 5. 8 、 7 7. 6 4 5 6 9 8. 7 0 0.4 7 2 2. 7 2 4 7 5 8. 7 7
2 、 7 7 4 、 9 2. 2 , 9 2. 7、 1 0 8. 3、 1 0 8 . 6、 1 0 9.2, 7 7 4, 9 2 2, 9 2 7, 1 0 8. 3, 1 0 8 6, 1 0 9.
0 、 1 0 9 1、 1 0 9. 3、 1 0 9. 6、 1 0 9 • 7 、 1 1 1 1、0, 1 0 9 1, 1 0 9. 3, 1 0 9. 6, 1 0 9 • 7, 1 1 1 1,
1 1 2 5 、 1 1 3 . 3 , 1 1 5. 7、 1 1 5. 9 、 1 1 5. 9 、 11 1 2 5 1 1 3 5 3 1 1 5. 7 1 1 5. 9 1 1 5. 9 1
6 - 2 、 1 1 6. 3 、 1 1 6. 7 , 1 1 7. 1、 1 1 7 . 3、 1 1 7.6-2, 1 1 6. 3, 1 1 6. 7, 1 1 7 1, 1 1 7 3, 1 1 7.
7 、 1 2 0 9、 1 2 6. 3、 1 2 6.6、 1 2 6. 8、 1 2 7. 0 、 2 7.2、 1 2 7.5、 1 3 8.0、 1 3 8.0、 1 3 8.2、 1 3 8• 3、 17, 1 2 0 9, 1 2 6. 3, 1 2 6.6, 1 2 6. 8, 1 2 7. 0, 2 7.2, 1 2 7.5, 1 3 8.0, 1 3 8.0, 1 3 8.2, 1 3 8 • 3, 1
3 8.4、 1 3 8.5、 1 4 1.2 、 1 4 2.0 、 1 4 3.1、 1 4 5 .1、 13 8.4, 1 3 8.5, 1 4 1.2, 1 4 2.0, 1 4 3.1, 1 4 5 1. 1
4 5.5、 1 4 5. 5、 1 4 5. 6、 1 4 5. 8、 1 4 6. 5、 1 4 6.4 5.5, 1 4 5. 5, 1 4 5. 6, 1 4 5. 8, 1 4 6. 5, 1 4 6.
5、 1 4 6. 6、 1 4 6.6、 1 4 6 . 7、 1 4 8. 1 , 1 4 9. 1、 15, 1 4 6. 6, 1 4 6.6, 1 4 6. 7, 1 4 8. 1, 1 4 9. 1, 1
6 6. 2、 1 6 6. 4、 1 6 9 .8、 1 6 9 . 9 、 1 7 0. 3、 1 7 0.6 6. 2, 1 6 6. 4, 1 6 9 .8, 1 6 9 9. 9, 1 7 0. 3, 1 7 0.
5、 1 7 0. 7、 1 7 1. 2、 1 7 1. 4 5, 1 7 0. 7, 1 7 1. 2, 1 7 1. 4
( 3 ) F A B -M S : m/ z = 9 3 5 [M- H]一  (3) F A B-M S: m / z = 9 3 5 [M-H]
(N e g a t i v e )  (N eg g at i v e)
T L Cにて F e C 1 3発色を行った所、 青く呈色した。 よって、 C o m p o u n d 2は水酸基を多く持つ化合物であることが示唆される。 また、 図 7に示す C o m p o u n d 2の1 3 C— NMRスぺク トルと、 図 8に示す C a s u a r i c t i nの 1 3 C— NMRのスぺク ト ノレを比 較すると非常に類似している。 なお、 C a s u a r i c t i nの構造式 を図 9に示す。 It was subjected to F e C 1 3 color by TLC, and blue coloration. Therefore, it is suggested that C ompound 2 is a compound having many hydroxyl groups. Further, the 13 C-NMR spectrum of C ompound 2 shown in FIG. 7 is very similar to the 13 C- NMR spectrum of C asuarictin shown in FIG. 8. Figure 9 shows the structural formula of Casuarictin.
以上の結果より、 C o m p o u n d 3は加水分解型のタンニン酸の 誘導体である可能性が非常に高く、 C a s u a r i c t i nのよ うな炭 素を 6個もつ糖の周りに 4〜 5個の没食子酸がエステル結合したような ものがついている構造であることが推察できる。 しかし、 C o m p o u n d 2の炭素数は 6 6個と多いため異性体と して、 二種類の化合物が 混ざっている可能性が示唆される。  From the above results, C ompound 3 is very likely to be a hydrolyzable derivative of tannic acid, and 4 to 5 gallic acid esters are present around a sugar having 6 carbons such as C asuarictin. It can be inferred that the structure has something like a bond. However, because the carbon number of C o m p o u n d 2 is as large as 66, it is suggested that the two types of compounds may be mixed as an isomer.
つさ (こ、 C o m p o u n d .1、 C o m p o u n d 2および C o m p o u n d 3について、 上述した方法と同様にしてチロシナーゼ阻害 率および S O D様活性を測定した結果を下記の表 3に示す。 また、 活性 指標物質と してアルブチンのチロシナーゼ阻害率および (+ ) —力テキ ンの S OD様活性を測定した結果を下記の表 4に示す。 表 3 The results of measuring tyrosinase inhibition rate and SOD-like activity for C ompound 1., C ompound 2 and C ompound 3 in the same manner as described above are shown in Table 3 below. The results obtained by measuring the tyrosinase inhibition rate of arbutin and the S OD-like activity of (+) — tekin are shown in Table 4 below. Table 3
<各種生理活性 >
Figure imgf000024_0001
<Various physiological activities>
Figure imgf000024_0001
処理濃度 チロシナーゼ阻害活性試験 1mg/ml  Treatment concentration Tyrosinase inhibitory activity test 1 mg / ml
SOD様活性試験 50 g/ml 表 4  SOD like activity test 50 g / ml Table 4
ぐ活性指標物質 >
Figure imgf000024_0002
Activity indicator substance>
Figure imgf000024_0002
処理濃度 チロシナ一ゼ阻害活性試験 5mg/ml  Treatment concentration Tyrosinase inhibitory activity test 5 mg / ml
SOD様活性試験 50 i /ml  SOD like activity test 50 i / ml
― ■■■ Not Test  ― ■ ■ ■ Not Test
このように、 C o m p o u n d 2は、 活性指標物質であるアルブチ ンと比較しても、 高いチロシナーゼ阻害活性を示した。 C o m p o u n d 1および 3は、 活性指標物質である (+ ) —力テキンとほぼ同様の S OD様活性を示した。 以上の結果より、 C o m p o u n d 1〜 3は イチゴ葉に含まれる生理活性物質であるといえる。 Thus, Compo n d 2 exhibited high tyrosinase inhibitory activity as compared to the activity indicator substance, albumin. C o m p o u n d 1 and 3 showed an S OD-like activity almost similar to that of the activity indicator (+)-force tekin. From the above results, it can be said that C o m p o u n d 1 to 3 are physiologically active substances contained in strawberry leaves.
〔花粉症の症状緩和効果〕 [The symptom alleviation effect of hay fever]
上述したオランダイチゴ葉抽出物を、 8人の花粉症に悩むパネラーに、 症状がでたときに使用してもらつたところ、 以下のよ うな結果を得た。 パネラー 1 (医師、 女性) : 私は、 花粉症により酷い鼻水やクシャミで 日常生活に支障をきたしていました。 もちろん、 これまで多くの改善薬 を使用してきましたが、 期待した効果のある薬品はありませんでした。 ところが、 もらった" イチゴ葉エキス" を症状の酷いときに鼻腔に塗布 して使用したところ、 4〜 5分で鼻水ゃクシャミが見事に止まり効果も 長時間に及びました。 それから、 毎日 2回程度を使用しておりますが副 作用的な傾向も全く感じられず快適に日常生活ができております。 The above-mentioned Dutch strawberry leaf extract was used by eight panelists suffering from hay fever when symptoms appeared, and the following results were obtained. Paneler 1 (doctor, woman): I was having trouble with daily life with severe runny nose and sneezing due to hay fever. Of course, we have used a lot of remedies, but none of them have the expected effect. However, when I received the "strawberry leaf extract" and applied it to the nasal cavity at the time of severe symptoms, in 4 to 5 minutes, the runny nose and Kushami will stop wonderfully and the effect also It lasted for a long time. Then, I use about twice a day, but I can feel comfortable everyday life without feeling any side effect.
パネラー 2 (主婦 4 7歳) : ガーデニングが趣味ですが、 花粉が飛ぶ時 期になると、 花粉症に悩まされていました。 「鼻腔に塗ってみたら」 と、 イチゴ葉エキスをいただき、 さっそく綿棒で塗るとクシャミが出て 1度 鼻をかんだだけで、 クシャ ミ · 鼻水 · 鼻詰まり も治まり、 3時間後もう 1度塗っただけで夕方まで気持ち良くガーデニングができました。  Paneler 2 (Housewife 4 and 7 years old): My hobby is gardening, but when pollen was about to fly, I was plagued by hay fever. "If I apply it to the nasal cavity," I have a strawberry leaf extract, and if I apply it with a cotton swab, I get a squeeze once and only blow my nose. I could do gardening comfortably until the evening.
パネラー 3 (主婦 3 8歳) :花粉症のため、 洗濯物を外に干す度に、 つ らい思いをしておりました。 イチゴ葉のエキスを貰い、 イチゴなら安心 と納得して、 鼻腔に綿棒で塗ったところ、 ひどい鼻水も止まり長時間効 くので嬉しく なつてしまいました。 も う離せないです。  Paneler 3 (Housewife 3 to 8 years old): Every time I washed the laundry out because of hay fever, I had a hard time thinking. I applied the strawberry leaf extract and was convinced that if it was a strawberry, I applied it to the nasal cavity with a cotton swab, and I was happy because the bad runny nose stopped and it worked for a long time. I can not let go.
パネラー 4 (インス トラクター 2 6歳):職場まで自転車で通っている のですが、 鼻詰まりやクシャミ、 また、 鼻水が止まらなくなったり しま した。 化粧も出来ない状態でした。 ある日、 鼻腔に塗ってごらんと、 ィ チゴ葉エキスのサンプルを頂き、 早速使った所、 鼻水もクシャミ も苦し い鼻詰まり もおさまり、 今は化粧をして通っています。 こんなに鼻炎に 効く物早く売り出して下さい。  Paneler 4 (Instructor 2 6 years old): I went to work by bicycle, but my nose was blocked, sore, and my runny nose stopped working. It was in the state where I could not do makeup. One day, I applied it to my nasal cavity and got a sample of fig leaf extract, and I used it immediately, and I had a runny nose, sneezing, and a bitter stuffy nose. Please sell products that are effective against rhinitis so quickly.
パネラー 5 (専業主婦 5 4歳) :イチゴ葉のエキス頂き本当に有難う御 座いました。 医者に行き色々薬を貰いましたが、 胃を悪く したり して、 心配の面もありました。 イチゴ葉エキスは匂いも良く、 私は花粉症より もハウスダス トの方がきっかつたのですが、 粘膜がガサガサになって剥 がれたり鼻血が出たり、 鼻詰り、 また鼻水が止まらなかったりが年中で した。 それがイチゴ葉エキスのお陰で粘膜も正常になり鼻も詰まらず鼻 水もあまり出なく なりました。 多くの苦しんでいる人達の為に早く製品 ィ匕して下さレ、。  Paneler 5 (A full-time housewife 5 4 years old): I really appreciate the strawberry leaf extract. I went to the doctor and gave me various medicines, but I also had problems with my stomach and getting worried. The strawberry leaf extract smells better, and I prefer house dust than hay fever, but the mucous membranes become loose and exfoliate, nosebleeds, stuffy nose, and runny nose does not stop. Was in the middle of the year. Because of that, thanks to the strawberry leaf extract, the mucous membranes are normal, the nose is not clogged, and the nasal discharge is not much. A quick product for many suffering people.
パネラー 6 (無職老人 7 2歳) :毎日プールに通って居るのですが、 こ の歳になっても急に花粉症になるのですね。 クシャミ と鼻水で、 最初は 風邪かと思って医院に行ったのですが、 花粉症と診断されました。 この 歳でと思いましたが、 医者に薬をもらいましたがあまり効果がありませ んでした。 プールの事務員さんが、 イチゴ葉エキスを 「綿棒に付けて鼻 の穴に塗り」 とくれました。 塗って 1 5分もすると鼻水もクシャミ も止 まりました。 良かったらサンプル上げると、 親切にして頂きました。 お 陰さまで機嫌よくプールに入れるようになりました。 即効性があり、 鼻 の中に塗っても良い匂いがしますので、 機嫌よく 日々過ごしています。 早く製品にしてください。 Paneler 6 (unemployed old man 7 2 years old): I go to the pool every day, Even if you get older, you suddenly have hay fever. At first I went to the doctor's office thinking that I had a cold, and I was diagnosed with hay fever. I thought this age, but I got a medicine from a doctor, but it didn't work very well. A clerk from the pool told me, “I put a strawberry leaf extract on a cotton swab and applied it to the nose hole”. After about 15 minutes of painting, the runny nose and sneezing stopped. If it is good, I will have you kindly when I raise a sample. I am now happy to be in the pool. It has immediate effect, and it smells good even if it's painted in the nose, so I spend my time in good mood. Please make it a product soon.
パネラー 7 ( 3 8歳主婦) :花粉が飛来するのを予測して、 一ヶ月以上 も前から注射や、 鼻の粘膜を焼くなどの花粉症対策をしたのに、 苦しい 症状は例年と変わらなかった。 イチゴ葉エキスを綿棒で鼻の奥に塗った ところ、 大変楽になった。 従来の薬は、 胃の調子が悪く なり、 胃薬を飲 まなければならない等の副作用が出たので、 イチゴ葉エキスを早く商品 ィ匕してほしい。  Paneler 7 (38-year-old housewife): Even though I took measures against pollinosis such as injection for a month or more and burning the mucous membranes of the nose in anticipation of flying pollen, the painful symptoms did not change from the previous year. The When I applied the strawberry leaf extract to the back of my nose with a cotton swab, it became very easy. As conventional medicines cause stomach upset and side effects such as having to take stomach medicines appear, I would like you to use strawberry leaf extract as a product.
パネラー 8 ( 6 4歳主婦) :花粉症歴 2 0年。 この時期はこうなるもの だと、 あきらめていましたが、 イチゴ葉エキスを鼻腔の奥に塗ったとこ ろ、 瞬間はクシャミが 5回続けて出て、 鼻水をかむと、 以後大変楽にな り、 鼻でスウスゥ息が出来るようになった。 また、 目がクシャタシャ し ていたのが、 それも楽になった。 以前は鼻の粘膜に力サブタが出来て苦 しく、 其れを取ると鼻血が出て、 また力サブタが出来て、 それの繰り返 しが続いたが、 イチゴ葉エキスを一日に 3回から 4回塗ることで楽な 日々を過ごせるようになりました。 花粉症は、 息をする最も大切な鼻が やられますので、 これの塗り薬ができたら、 私が長年苦しめられてきま したので、 どんなに嬉しいだろう と思いました。 とにかくイチゴ葉ェキ スで大変楽になりました。 このよ う に、 粘膜に作用して優れた抗アレルギー作用、 抗ヒスタ ミ ン 作用を発揮し、 特に鼻粘膜に作用して鼻水やクシャミ等のいわゆる花粉 症の症状を緩和することができ、 鼻粘膜等の粘膜に対する粘膜外用剤と して利用することができる。 また、 優れた抗アレルギー作用によりァレ ルギー性の皮膚炎等の治療や緩和効果も期待できる。 産業上の利用可能性 Paneler 8 (64-year-old housewife): Pollinosis history 20 years. If this time was this, I gave up, but when I applied the strawberry leaf extract to the back of the nasal cavity, in the moment Kushami went out five times in a row, and it became very easy from now on, when I had a runny nose. I can breathe suussu with my nose. Also, it was easier for my eyes to be crushing. In the past, it was difficult to make the nasal mucous membrane a power subta, and when I took it I got nosebleed, and then I made a physical subta and repeated it, but the strawberry leaf extract was repeated 3 times a day. I have been able to spend an easy day by painting four times. Hay fever is the most important nose to breathe, so I thought that I would be glad if I could apply for this medicine, because I had been suffering for many years. Anyway, it was very easy with strawberry leaves. Thus, it acts on the mucous membrane to exert excellent anti-allergic and antihistamine actions, and in particular it acts on the nasal mucous membrane to alleviate the symptoms of so-called pollinosis such as runny nose and mucilage, etc. It can be used as an external preparation for mucous membranes such as mucous membranes. In addition, due to the excellent antiallergic action, therapeutic and alleviating effects such as allergic dermatitis can be expected. Industrial applicability
本発明の皮膚外用剤は、 高いチロシナーゼ活性阻害作用を有し、 また 抗菌活性を有しているので、 美白用化粧品をはじめ、 二キビ、 しみの防 止、 治療を目的とする皮膚外用剤と して用いることができる。 また、 鼻 粘膜等の粘膜に対する粘膜外用剤と して用いることができる。  Since the external preparation for skin of the present invention has a high tyrosinase activity inhibitory action and also an antibacterial activity, it is an external preparation for skin care intended for the prevention of acne and stains and treatment including skin lightening cosmetics. Can be used. It can also be used as an external preparation for mucous membranes such as nasal mucous membranes.

Claims

請求の範囲 l . バラ科オランダイチゴ属植物の葉および Zまたは茎のエキスを有効 成分と して含有することを特徴とする皮膚外用剤。 Claims 1. An external preparation for skin comprising an extract of leaves and Z or stems of a plant belonging to the genus Rosaceae of the genus Rosaceae as an active ingredient.
2 .上記バラ科オランダイチゴ属植物の葉および または茎のエキスは、 水および またはアルコールで抽出した抽出物である請求項 1記載の皮 膚外用剤。 2. The external preparation for skin according to claim 1, wherein the extract of leaves and or stems of the plant of the genus Rosaceae of the family Rosaceae is an extract extracted with water and / or alcohol.
3 . バラ科オランダイチゴ属植物の葉および Zまたは茎のエキスを有効 成分と して含有することを特徴とする粘膜外用剤。 3. An external preparation for mucous membranes comprising an extract of leaves and Z or stems of a plant belonging to the genus Rosaceae of the genus Rosaceae as an active ingredient.
4 .上記バラ科オランダイチゴ属植物の葉および または茎のエキスは、 水および またはアルコールで抽出した抽出物である請求項 3記載の粘 膜外用剤。 4. The external preparation for external layer according to claim 3, wherein the extract of leaves and or stems of the plant of the genus Rosaceae of the family Rosaceae is an extract extracted with water and / or alcohol.
PCT/JP2007/072150 2006-11-14 2007-11-08 External preparation for skin and external preparation for mucosa WO2008059906A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2006307365 2006-11-14
JP2006-307365 2006-11-14
JP2007099276 2007-04-05
JP2007-099276 2007-04-05
JP2007285634A JP2008273922A (en) 2006-11-14 2007-11-02 External preparation for skin and external preparation for mucosa
JP2007-285634 2007-11-02

Publications (1)

Publication Number Publication Date
WO2008059906A1 true WO2008059906A1 (en) 2008-05-22

Family

ID=39401710

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/072150 WO2008059906A1 (en) 2006-11-14 2007-11-08 External preparation for skin and external preparation for mucosa

Country Status (1)

Country Link
WO (1) WO2008059906A1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03188014A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Cosmetic
JPH03188008A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Cosmetic
WO1997002807A1 (en) * 1995-07-07 1997-01-30 C 3 D Depigmenting cosmetic skin-care composition and use thereof
JP2002179586A (en) * 2000-12-15 2002-06-26 Fancl Corp Lipase inhibitor
JP2003261455A (en) * 2002-03-07 2003-09-16 Pias Arise Kk Antiallergy agent
JP2003261454A (en) * 2002-03-06 2003-09-16 Pias Arise Kk ANTIINFLAMMATORY AGENT, PGE2 PRODUCTION INHIBITOR, IL-1alpha PRODUCTION INHIBITOR AND IL-6 PRODUCTION INHIBITOR
JP2004115466A (en) * 2002-09-27 2004-04-15 Toyo Shinyaku:Kk Skin care preparation for external use
JP2004123622A (en) * 2002-10-03 2004-04-22 Toyo Shinyaku:Kk Preparation for external use for ameliorating blood circulation
JP2004131500A (en) * 2002-09-19 2004-04-30 Fancl Corp Skin aging inhibitor or improver

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03188014A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Cosmetic
JPH03188008A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Cosmetic
WO1997002807A1 (en) * 1995-07-07 1997-01-30 C 3 D Depigmenting cosmetic skin-care composition and use thereof
JP2002179586A (en) * 2000-12-15 2002-06-26 Fancl Corp Lipase inhibitor
JP2003261454A (en) * 2002-03-06 2003-09-16 Pias Arise Kk ANTIINFLAMMATORY AGENT, PGE2 PRODUCTION INHIBITOR, IL-1alpha PRODUCTION INHIBITOR AND IL-6 PRODUCTION INHIBITOR
JP2003261455A (en) * 2002-03-07 2003-09-16 Pias Arise Kk Antiallergy agent
JP2004131500A (en) * 2002-09-19 2004-04-30 Fancl Corp Skin aging inhibitor or improver
JP2004115466A (en) * 2002-09-27 2004-04-15 Toyo Shinyaku:Kk Skin care preparation for external use
JP2004123622A (en) * 2002-10-03 2004-04-22 Toyo Shinyaku:Kk Preparation for external use for ameliorating blood circulation

Similar Documents

Publication Publication Date Title
EP2370052B1 (en) Novel sebum secretion inhibitory agent
JP7275103B2 (en) Novel cosmetic use of Nephelium lapaceum extract
EP2654762B1 (en) Extract of the aerial parts of gynandropsis gynandra and cosmetic, dermatoligic and pharmaceutic compositions comprising the extract
FR3076460A1 (en) COSMETIC USE OF A PROTEIN EXTRACT FROM MORINGA OLEIFERA SEEDS
EP3203981B1 (en) Deglycation activity of a combination of an extract of salvia miltiorrhiza and niacin and/or niacinamide
JP2013502380A (en) Skin refining complex, use of said complex, cosmetic or pharmaceutical composition comprising said complex and method for its application
KR102142311B1 (en) Skin external composition comprising tangeretin
JP2008273922A (en) External preparation for skin and external preparation for mucosa
US20130028849A1 (en) Agent For Stimulating The Expression of Loxl
JP2008143827A (en) Skin care preparation, skin-lightening agent and composition for internal use
KR102300580B1 (en) Cosmetic compositions comprising a Vin Chaud extract
WO2008059906A1 (en) External preparation for skin and external preparation for mucosa
JP4457133B2 (en) External preparation for skin and whitening agent
JP2008247787A (en) External preparation for skin
JP2007045734A (en) External preparation for skin and hyaluronidase inhibitor
JP3799340B2 (en) Hydroxytyrosol, application to topical skin preparation
JPWO2005084613A1 (en) Skin preparation
JP6823938B2 (en) Topical skin agent
FR3099702A1 (en) New cosmetic use of an extract of Epilobium angustifolium
FR3110416A1 (en) Ylang-ylang absolute for use as a cosmetic active
JP2005272349A (en) Natural cosmetic
FR3099701A1 (en) New cosmetic use of a combination of oenothein-B and quercetin-3-O-glucuronide
FR3110421A1 (en) Narcissus poeticus extract for its cosmetic use
FR3030275A1 (en) USE OF A LYTHRUM SALICARIA EXTRACT
JP2023155109A (en) Skin improvement composition containing wild geranium extract with excellent antioxidant, whitening and anti-inflammatory effects

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07831880

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC EPO FORM 1205A MAILED 27.07.09

122 Ep: pct application non-entry in european phase

Ref document number: 07831880

Country of ref document: EP

Kind code of ref document: A1